Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0258916B2 - - Google Patents
[go: Go Back, main page]

JPH0258916B2 - - Google Patents

Info

Publication number
JPH0258916B2
JPH0258916B2 JP58161946A JP16194683A JPH0258916B2 JP H0258916 B2 JPH0258916 B2 JP H0258916B2 JP 58161946 A JP58161946 A JP 58161946A JP 16194683 A JP16194683 A JP 16194683A JP H0258916 B2 JPH0258916 B2 JP H0258916B2
Authority
JP
Japan
Prior art keywords
dna
double
stranded
hybrid
hind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58161946A
Other languages
Japanese (ja)
Other versions
JPS6054684A (en
Inventor
Tsutae Morinaga
Kinichiro Miura
Kunitada Shimotoono
Masato Ikegami
Yataro Ichikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP58161946A priority Critical patent/JPS6054684A/en
Priority to US06/643,036 priority patent/US4855237A/en
Priority to DE8484110116T priority patent/DE3484039D1/en
Priority to EP84110116A priority patent/EP0136521B1/en
Publication of JPS6054684A publication Critical patent/JPS6054684A/en
Publication of JPH0258916B2 publication Critical patent/JPH0258916B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203Virus mediated transformation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/948Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

発明の技術分野 本発明は、ビーンゴールデンモザイクウイルス
(Been、Golden Mosaic Virus;以下これを
“BGMV”と略称することがある)に関連する
DNA及びそれを組み込んだハイブリツドDNAに
関する。更に詳しく説明するとBGMVの一本鎖
DNAを二本鎖化して得られたDNA、このDNA
を他の生物用ベクターに組み込んで得られたハイ
ブリツドDNA、このハイブリツドDNAを増殖す
ることによつて得られたハイブリツドDNA、こ
のハイブリツドDNAからBGMV由来のDNA断
片部分のみを取り出して閉環結合して得られた
DNA及びBGMVの複製型DNAに関する。 従来技術 ウイルスからのDNA遺伝子は、最近遺伝子組
み換え技術において、広くベクターとして開発さ
れて利用されている。そのようなベクターを与え
るウイルスの例としてはシミアンウイルス(SV)
40やポリオーマウイルスの如きパポバウイルス、
パピロマウイルス、アデノウイルスの如きものが
知られている。しかしこれら公知のベクターは動
物系のベクターとして見出されたものであつて、
植物系の細胞中では増殖しない。従つてこれら公
知のベクターは植物遺伝子組み換え用のベクター
としては利用出来ない。 現在までに植物遺伝子組み換え用ベクターとし
て利用可能性のあるものとしては、例えばトマト
やタバコなどの双子葉類植物に腫瘍を作るアグロ
バクテリウムチユームフアシイエン
(Agrobacterium tumefaciens)が有している核
外遺伝子のTiプラスミド、キヤベツや白菜など
に病気を起すカリフラワーモザイクウイルスから
のDNA遺伝子などが知られているのみである。
これら以外に植物遺伝子組み換え用ベクターとし
て適切なものは未だ開発されていない。更に植物
遺伝子組み換えのベクターになりうる可能性のあ
るDNA遺伝子を有する植物ウイルスは前掲のカ
リフラワーモザイクウイルス以外は知られていな
かつたと云つてよい。 最近米国のイリノイ大学のロバート・エム・グ
ツドマン(Robert.M.Goodman)らは熱帯性の
植物ウイルスであるBSMVの遺伝子は、その直
径が約18nmの2つの粒子が対合した如き形態で
1個のビリオンをなすものでありその核酸を解析
した結果、このウイルスの遺伝子が約2500塩基の
大きさの環状一本鎖のDNAであることを見出し
報告している〔Virology83 171(1977)、
Virology97 388(1979)参照〕。 このような約18nmの直径を有する2つの粒子
が対合した如き形態で1個のビリオンをなし、し
かもその遺伝子が環状の一本鎖である様な植物ウ
イルスがその後数種類発見されこれら一群のウイ
ルスは“ジエミニウイルス群”と呼ばれている。 前述したように植物のDNA型ウイルスは、カ
リフラワーモザイクウイルスとジエミニウイルス
とが知られているに過ぎず、植物遺伝子組み換え
用ベクターの開発の目標としてジエミニウイルス
は極めて期待出来る。 従来、植物遺伝子組み換え用ベクターに関して
提案されている前記Tiプラスミドやカリフラワ
ーモザイクウイルスは感染する植物つまり宿主植
物が双子葉類に限られているのに対し、ジエミニ
ウイルスは双子葉類のみならず、人類にとつて重
要穀物である麦、トウモロコシの如き単子葉類も
宿主となりうるので、このジエミニウイルスの
DNAを植物遺伝子組み換え用のためにベクター
化することはそれ自体極めて意味あることであ
る。 一方カリフラワーモザイクウイルスは植物細胞
の細胞室内で増殖するのに対し、ジエミニウイル
スは細胞質内でもまた核の中でも増殖する。この
ことはジエミニウイルスをベクター化した場合、
植物の核遺伝子そのものを改変し得る可能性が高
いことを示している。従つて、ジエミニウイルス
のDNAをベクター化することが出来ればそのこ
と自体工業的に価値あることであることは明白で
ある。 本発明の構成 そこで本発明者らは、ジエミニウイルスの一種
であるビーンゴールデンモザイクウイルス
(BGMV)の一本鎖DNAを遺伝子組み換え操作
において技術的に取り扱い易い二本鎖化しベクタ
ーとすること、それに組み込んだハイブリツド
DNAなどについて研究を進めた結果本発明の到
達したものである。 すなわち、本発明によれば、BGMVからの(i)
長さが約2.5キロ塩基の一本鎖DNAを少くとも部
分的に二本鎖化して得られたDNAであり図a
の制限酵素地図を示すDNA(以下これをDNA−
aと略す)及び(ii)長さが約2.61キロ塩基の一本
鎖DNAを少くとも部分的に二本鎖化して得られ
たDNAであり図bの制限酵素地図を示すDNA
(以下これをDNA−bと略す)がまた、本発明
によれば前記二本鎖化したDNA−a及びDNA
−bを制限酵素で分解し、同じ制限酵素で開裂
した他の生物用ベクターに組み込んで得られたハ
イブリツドDNA、このハイブリツドDNAを元の
ベクターの宿主に戻して増殖を行つて得られたハ
イブリツドDNA、このハイブリツドDNAを制径
酵素で分解し次いで閉環結合することにより得ら
れた図a又はbの制限酵素切断地図を示す
DNAが提供される。 さらに本発明によればこれらDNAの塩基配列
を含有した複製型DNAが提供される。 ビーンゴールデンモザイクウイルス(BGMV)
は中南米においてインゲン豆類にゴールデンモザ
イク様の病気を起すウイルスであり、
Phytopathology 67(No.1)37(1977)記載の方
法で感染植物から下記の如く純化しその一本鎖
DNAを分離・精製することができる。 (1) BGMVからの一本鎖DNAの分離 前記文献記載の方法により感染植物からウイ
ルスを純化し、次いで得られた純化ウイルス約
500μgを30mM Tris HCl(PH=7.6)1%
SDS、プロテエネースK 10μg/ml液にて2
分間振盪し、次にフエノール700μで3回タ
ンパク質抽出を行つた。水層から溶液フエノー
ルをエーテル抽出により除き、次にエタノール
沈澱法によりウイルスの一本鎖DNAを分離・
精製し得る。 (2) BGMVの一本鎖DNAの二本鎖化 上記の如くして得た一本鎖DNAを次にin
vitroで二本鎖化する。この二本鎖化において
は一本鎖DNA1μg当り、プライマーを0.002〜
2000μgの割合で使用するのが好ましい。プラ
イマーとしては、ジエイ・エム・テイラー(J.
M.Tayler)らのBiochimica et Biophysica
Acta,442 325(1976)記載の方法を改変して
仔牛胸線DNAをDNaseで分解して得たオリ
ゴヌクレオチドを使用することが出来る。本発
明者らは後述する実施例記載の如く、この改変
した方法で得られたプライマーを使用した。こ
のオリゴヌクレオチドをプライマーとして使用
する場合のプライマーの量は前記一本鎖
DNA1μg当り50〜400μg、より好ましくは
100〜300μgの割合が適当である。 またBGMVの一本鎖DNAに対しプライマー
として少くとも10塩基を含み且つ全く相補的な
配列をする純化DNAを使用する場合には、プ
ライマーの使用割合は一本鎖DNA1μg当り、
0.002μg〜1μg、更には0.004μg〜0.02μgで
あつてもよい。 前述の割合で一本鎖DNAに対してプライマ
ーを添加して後デオキシアデノシン三リン酸
(dATP)、デオキシシチジン三リン酸
(dCTP)、デオキシグアノシン三リン酸
(dGTP)及びデオキシチミジン三リン酸
(dTTP)のそれぞれを最終濃度10〜300μM、
好ましくは50〜150μMの範囲となるように添
加使用する。 この際、例えばdCTPの一部をd−32P−デ
オキシシチジン三リン酸(d−32P−dCTP)
に置換しておくと、その後の反応において二本
鎖化の進行度合、二本鎖化DNAの追跡が容易
となるので便利である。また酵素反応を捉進す
るためにMg++(例えば塩化マグネシウム、硫
酸マグネシウムなどを1〜50mM、好ましくは
5〜21mMの濃度範囲で使用する。なお本明細
書にいて「M」は特にことわらない限り
「mol/」の濃度単位を意味する。反応系内
のPHは7.2〜9、好ましくは7.6〜8.4の範囲に維
持されるように緩衝剤、例えばTris HCl(PH
7.6〜8.4)を30〜300mM、好ましくは70〜
200mMの濃度となるように使用するのが有利
である。かくして上記混合液を好ましくは50〜
80℃、特に60〜70℃の温度に1〜10分間、好ま
しくは3〜7分間維持し次いで必要ならば約0
℃もしくはそれ以下の温度に急冷する。 なお混合液全体の量は、ベクター一本鎖
DNA1μg当り、1〜1000μ、好ましくは10
〜500μの範囲とするのがよい。また酵素安
定剤として通常使用されるものを用いることは
効果的であり、その例としては例えばα−メル
カプトエタノール、ジチオスレイトール
(DTT)が挙げられる。安定剤は混合液中の濃
度として0.1〜5(重量)%、好ましくは0.5〜
2(重量)%の範囲で用いることができる。 次に二本鎖化用の酵素を作用させるが、その
二本鎖化のための酵素としては例えばエイビア
ン・ミエロブラストシス・ウイルス(AMV)
の逆転写考素、T4−DNAポリメラーゼ、大腸
菌DNAポリメラーゼI、DNAポリメラーゼ・
ラージフラグメント(クレノーエンザイム)な
どが挙げられる。このうちAMVの逆転写酵素
又はDNAポリメラーゼ・ラージフラグメント
が好ましい。 二本鎖化酵素の使用割合は、主としてその種
類によつて左右される。例えばAMVの逆転写
酵素は〔生化学工業(株)製コード120248を使用す
る場合には〕一本鎖DNA1μg当り、1〜20ユ
ニツト、好ましくは5〜10ユニツト使用するの
が有効である。1ユニツトより少ないと二本鎖
化が充分に行なわれにくくなることがある。二
本鎖化酵素を加えた後、先ず10〜30℃、好まし
くは15〜25℃の温度で2〜30分間、好ましくは
5〜20分間反応させ次いで30〜45℃、好ましく
は35〜40℃の温度で30〜180分間、好ましくは
50〜120分間反応させるのが有利である。 反応を停止させるには反応混合液に例えば水
飽和フエノール或いはEDTA水溶液(PH=8.0)
などの停止剤を加えればよい。その際水飽和フ
エノールの場合は反応混合液に対し1/10〜2
容量倍加え振盪後遠心により水層のみを分離分
取すればよく、またEDTA水溶液の場合には
混合液中存在するMg++を捕捉するに充分な量
使用すればよい。かくして反応停止処理を行つ
たDNA含有水溶液から二本鎖化したDNAを分
離すればよく、好ましい分離操作はゲル口過に
よる方法である。その場合の一具体例について
説明すると、二本鎖化したDNA含有水溶液を、
Sephadex G−10〔フアルマシア・フアインケ
ミカル(株)製〕やBiogel p30〔バイオ・ラド(株)
製〕などのゲル口過剤を用いて分画を行ない各
画分の32p強度を側定し、各画分中で最初に出
てくる32p強度の高い分子量のDNA含有画分
を集め、これをエタノール又はイソプロパノー
ル中で沈澱を行なえば二本鎖化したDNAが得
られる。かくして分離された二本鎖化DNAは、
BGMVの一本鎖DNAに基づく二本鎖化DNA
以外のプライマーDNAを可成り含んでいるこ
とがある。この傾向はプライマーとして前記仔
牛胸線DNAからのオリゴヌクレオチドを用い
た場合に著しい。 従つて、そのような場合二本鎖化したDNA
を一層高純度とするために、再度精製すること
が望ましい。この精製は前述した如きゲル口過
による方法を用いて行うことができる。その一
具体例を示すと、一本鎖DNA20μgから出発
した場合、前記二本鎖化DNAを水100〜500μ
に溶解し10mM Tris BCl(PH=7.4)、
100mM NaCl水溶液で平衡化したSephadex
G−50又はBiogel p30を充填した分離能を高
めたカラムにてゲル口過を行なう。溶出液とし
て10mM Tris HCl(PH=7.4)、100mM NaCl
を使用しボイドボリームのうち32pカウントの
高い画分を集め、エタノール又はイソプロパノ
ール中で沈澱を行ない高純度のBGMVの二本
鎖化DNAを得ることができる。 (3) 二本鎖化DNA 前記したBGMVにおけるジエミニウイルス
は2種のDNAが存在し前述の如く二本鎖化し
て得られたDNAもまた2種存在する。この2
種の二本鎖化DNAは、それぞれのDNAに分離
することができ、またクローニング化した後分
けることができる。また二本鎖化する前に(つ
まり一本鎖DNAの状態で)それぞれを分離し、
それぞれについて同様に二本鎖化を行うことも
できる。 BGMVの一本鎖DNAの混合物をDNA−a
とDNA−bとの分離するには所謂“ストラン
ドセパレーシヨン”を呼ばれている方法、〔例
えばマニアテイスらの著書“Molecular
Cloning A Laboraory Manual”第180〜
185頁記載の方法〕つまりゲル電気泳動法によ
る方法やまたDNA混合物の塩化セシウム溶液
にa又はbのいずれか一方のDNAのみに
相補的なDNA断片を加えて平衡密度勾配遠心
により一本鎖のままで残つたDNAと、一部分
二本鎖化されたDNAとの密度差を利用して分
離する方法を採用することが可能である。 しかしDNA−aとDNA−bの分離は一
本鎖DNA混合物を二本鎖化して後、例えばプ
ラスミドpBR322などへクローニングした後分
離する方が分離し易い。この分離法については
後に詳細に説明する。 かくしてBGMVからのDNAを二本鎖化して
得られたDNAは、その一方が2.57±0.1キロ塩
基対(以下“キロ塩基対”を“Kpb”と略称す
ることがある)の大きさを有し図aの制限酵
素切断地図を示す。また他方は2.61±0.1キロ
塩基対(Kbp)の大きさを有し図bの制限酵
素切断地図を示す。 図aでは、Hindによる切断部位を
〔0.0/2.57〕として各制限位置を位置座標とし
て示されており、単位はキロ塩基対(Kbp)で
ある。また図bではHindの1つの位置を
〔0.0/2.61〕として各制限部位を位置座標とし
て示されている。 次に各制限酵素による分解により生じる断片
を下記表1に示した。表中断片の大きさに比較
して濃く出る断片をAグループにその他をBグ
ループに分けて示した。
Technical Field of the Invention The present invention relates to Been, Golden Mosaic Virus (hereinafter sometimes abbreviated as "BGMV").
Concerning DNA and hybrid DNA incorporating it. To explain in more detail, the single strand of BGMV
DNA obtained by double-stranding DNA, this DNA
Hybrid DNA obtained by inserting BGMV into a vector for other organisms, Hybrid DNA obtained by propagating this hybrid DNA, and Hybrid DNA obtained by extracting only the BGMV-derived DNA fragment from this hybrid DNA and circularly ligating it. was given
Concerning DNA and replicative DNA of BGMV. Prior Art Recently, DNA genes from viruses have been widely developed and used as vectors in genetic recombination technology. An example of a virus that provides such a vector is the simian virus (SV).
40 and papovaviruses such as polyomavirus,
Papillomaviruses and adenoviruses are known. However, these known vectors were discovered as animal-based vectors, and
It does not proliferate in plant cells. Therefore, these known vectors cannot be used as vectors for plant genetic recombination. To date, vectors that can be used as plant genetic modification vectors include the extranuclear vector possessed by Agrobacterium tumefaciens, which causes tumors in dicotyledonous plants such as tomatoes and tobacco. The only known genes are the Ti plasmid and the DNA gene from the cauliflower mosaic virus, which causes diseases in cabbage and Chinese cabbage.
Other than these, vectors suitable for plant genetic recombination have not yet been developed. Furthermore, it can be said that no plant virus other than the above-mentioned cauliflower mosaic virus is known to have a DNA gene that could potentially serve as a vector for plant genetic recombination. Recently, Robert M. Goodman of the University of Illinois in the United States and his colleagues have discovered that the gene of BSMV, a tropical plant virus, is composed of two paired particles with a diameter of approximately 18 nm. As a result of analyzing its nucleic acid, it was discovered and reported that the gene of this virus is a circular single-stranded DNA with a size of approximately 2500 bases [Virology 83 171 (1977),
See Virology 97 388 (1979)]. Subsequently, several types of plant viruses were discovered that have a form in which two particles with a diameter of about 18 nm pair together to form a single virion, and whose genes are circular single-stranded. are called the “gieminivirus group”. As mentioned above, the only known plant DNA viruses are cauliflower mosaic virus and dieminivirus, and dieminivirus is extremely promising as a target for the development of vectors for plant genetic modification. Conventionally, the Ti plasmid and cauliflower mosaic virus, which have been proposed as vectors for plant genetic modification, can only infect dicotyledonous plants, that is, host plants, whereas dieminivirus can be used not only for dicotyledonous plants, but also for dicotyledonous plants. Monocots such as wheat and corn, which are important grains for humans, can also serve as hosts, so this dieminivirus is
Converting DNA into a vector for plant genetic modification is in itself extremely significant. On the other hand, cauliflower mosaic virus multiplies within the cell chambers of plant cells, whereas dieminivirus multiplies both within the cytoplasm and within the nucleus. This means that when the dieminivirus is made into a vector,
This indicates that it is highly possible to modify the nuclear genes of plants themselves. Therefore, it is clear that it would be industrially valuable if the DNA of dieminivirus could be transformed into a vector. Structure of the present invention Therefore, the present inventors have developed the single-stranded DNA of bean golden mosaic virus (BGMV), which is a type of dieminivirus, into a double-stranded vector that is technically easy to handle in genetic recombination operations, and built-in hybrid
The present invention was achieved as a result of research into DNA and the like. That is, according to the present invention, (i) from BGMV
It is DNA obtained by at least partially making double-stranded single-stranded DNA with a length of about 2.5 kilobases.
DNA showing the restriction enzyme map of (hereinafter referred to as DNA−
(abbreviated as a) and (ii) DNA obtained by at least partially double-stranding a single-stranded DNA with a length of about 2.61 kilobases and showing the restriction enzyme map shown in Figure b.
(hereinafter abbreviated as DNA-b), but according to the present invention, the double-stranded DNA-a and DNA
Hybrid DNA obtained by digesting -b with a restriction enzyme and inserting it into another biological vector cleaved with the same restriction enzyme, and hybrid DNA obtained by returning this hybrid DNA to the original vector host and propagating it. , shows the restriction enzyme cleavage map of diagram a or b obtained by decomposing this hybrid DNA with a restriction enzyme and then ring-closing ligation.
DNA provided. Furthermore, the present invention provides replicative DNA containing the base sequences of these DNAs. Bean golden mosaic virus (BGMV)
is a virus that causes golden mosaic-like disease in kidney beans in Central and South America.
Phytopathology 67 (No. 1) 37 (1977) was used to purify the following single strand from infected plants.
DNA can be isolated and purified. (1) Isolation of single-stranded DNA from BGMV Virus was purified from infected plants by the method described in the above literature, and then the purified virus
500μg in 30mM Tris HCl (PH=7.6) 1%
SDS, Proteene K 10 μg/ml solution 2
Shake for minutes and then perform protein extraction three times with 700μ of phenol. The solution phenol was removed from the aqueous layer by ether extraction, and then the single-stranded DNA of the virus was separated by ethanol precipitation.
Can be purified. (2) Double-stranding the single-stranded DNA of BGMV The single-stranded DNA obtained as described above is then injected into
Double-stranded in vitro. In this double-stranded formation, 0.002 ~
Preferably, it is used at a rate of 2000 μg. As a primer, G.M. Taylor (J.
Biochimica et Biophysica by M.Tayler et al.
An oligonucleotide obtained by degrading calf thymus DNA with DNase can be used by modifying the method described in Acta, 442 325 (1976). The present inventors used primers obtained by this modified method as described in the Examples below. When using this oligonucleotide as a primer, the amount of primer is
50 to 400 μg per μg of DNA, more preferably
A proportion of 100 to 300 μg is suitable. In addition, when using purified DNA containing at least 10 bases and having a completely complementary sequence as a primer to the single-stranded DNA of BGMV, the ratio of primer used is per 1 μg of single-stranded DNA.
The amount may be 0.002 μg to 1 μg, or even 0.004 μg to 0.02 μg. Deoxyadenosine triphosphate (dATP), deoxycytidine triphosphate (dCTP), deoxyguanosine triphosphate (dGTP) and deoxythymidine triphosphate ( dTTP) each at a final concentration of 10-300 μM,
It is preferably added in a range of 50 to 150 μM. At this time, for example, a part of dCTP is converted into d-32P-deoxycytidine triphosphate (d-32P-dCTP).
It is convenient to substitute , as it makes it easy to track the progress of double-stranded DNA and the double-stranded DNA in subsequent reactions. In addition, Mg ++ (e.g., magnesium chloride, magnesium sulfate, etc.) is used in a concentration range of 1 to 50 mM, preferably 5 to 21 mM, in order to accelerate the enzymatic reaction. Unless otherwise specified, it means the concentration unit of "mol/".A buffer such as Tris HCl (PH
7.6-8.4) at 30-300mM, preferably 70-300mM
Advantageously, a concentration of 200mM is used. Thus, the above mixture is preferably 50~
Maintain at a temperature of 80°C, especially 60-70°C, for 1-10 minutes, preferably 3-7 minutes, then if necessary
Rapid cooling to ℃ or lower. Note that the total amount of the mixture is based on vector single-stranded
1 to 1000μ, preferably 10 per μg of DNA
It is preferable to set it in the range of ~500μ. It is also effective to use commonly used enzyme stabilizers, such as α-mercaptoethanol and dithiothreitol (DTT). The concentration of the stabilizer in the mixed solution is 0.1 to 5% (by weight), preferably 0.5 to 5% (by weight).
It can be used in a range of 2% (by weight). Next, an enzyme for double-stranding is applied, and examples of the enzyme for double-stranding include Avian myeloblastosis virus (AMV).
reverse transcription factor, T4-DNA polymerase, Escherichia coli DNA polymerase I, DNA polymerase
Examples include large fragment (Klenow enzyme). Among these, AMV reverse transcriptase or DNA polymerase large fragment is preferred. The proportion of double-stranded enzyme used depends primarily on its type. For example, when using AMV reverse transcriptase (code 120248 manufactured by Seikagaku Corporation), it is effective to use 1 to 20 units, preferably 5 to 10 units, per 1 μg of single-stranded DNA. If the number is less than 1 unit, it may be difficult to form double strands sufficiently. After adding the double-stranded enzyme, the reaction is first carried out at a temperature of 10-30°C, preferably 15-25°C for 2-30 minutes, preferably 5-20 minutes, and then 30-45°C, preferably 35-40°C. 30-180 minutes at a temperature of preferably
It is advantageous to react for 50 to 120 minutes. To stop the reaction, add water-saturated phenol or EDTA aqueous solution (PH = 8.0) to the reaction mixture.
You can add a stopper such as In the case of water-saturated phenol, 1/10 to 2
It is only necessary to separate and collect only the aqueous layer by doubling the volume, shaking, and centrifuging, and in the case of an EDTA aqueous solution, it is sufficient to use an amount sufficient to capture Mg ++ present in the mixture. The double-stranded DNA may be separated from the DNA-containing aqueous solution that has been subjected to the reaction termination treatment, and a preferred separation operation is a gel filtration method. To explain one specific example of that case, a double-stranded DNA-containing aqueous solution is
Sephadex G-10 [manufactured by Pharmacia Huain Chemical Co., Ltd.] and Biogel p30 [Bio-Rad Co., Ltd.]
The 32p intensity of each fraction is determined by fractionation using a gel filtration reagent such as the one manufactured by J.D. By precipitating the DNA in ethanol or isopropanol, double-stranded DNA can be obtained. The double-stranded DNA thus separated is
Double-stranded DNA based on the single-stranded DNA of BGMV
may contain a considerable amount of primer DNA other than the This tendency is remarkable when oligonucleotides from the calf thymus DNA are used as primers. Therefore, in such cases double-stranded DNA
It is desirable to purify it again to make it even more pure. This purification can be carried out using the gel filtration method described above. To give a specific example, when starting from 20 μg of single-stranded DNA, add the double-stranded DNA to 100 to 500 μg of water.
Dissolved in 10mM Tris BCl (PH=7.4),
Sephadex equilibrated with 100mM NaCl aqueous solution
Gel filtration is performed using a column packed with G-50 or Biogel p30 with enhanced separation ability. 10mM Tris HCl (PH=7.4), 100mM NaCl as eluent
High purity BGMV double-stranded DNA can be obtained by collecting the fraction with a high 32p count from the void volume using a method and precipitating it in ethanol or isopropanol. (3) Double-stranded DNA There are two types of DNA in the dieminivirus in BGMV described above, and there are also two types of DNA obtained by double-stranded DNA as described above. This 2
The double-stranded DNA of a species can be separated into individual DNAs, or can be cloned and then separated. Also, before making double strands (in other words, in the state of single stranded DNA), separate each
Double stranding can also be performed in the same way for each. DNA-a mixture of single-stranded DNA of BGMV
To separate DNA-b and DNA-b, a method called “strand separation” is used [for example, in the book “Molecular
Cloning A Laboratory Manual” No. 180~
[method described on page 185] That is, a method using gel electrophoresis, or a DNA fragment complementary to either DNA a or b is added to a cesium chloride solution of a DNA mixture, and single strands are isolated by equilibrium density gradient centrifugation. It is possible to employ a separation method that utilizes the density difference between the DNA that remains intact and the partially double-stranded DNA. However, it is easier to separate DNA-a and DNA-b by converting the single-stranded DNA mixture into double-strands, for example, cloning them into plasmid pBR322, etc., and then separating them. This separation method will be explained in detail later. Thus, the DNA obtained by double-stranding the DNA from BGMV has a size of 2.57 ± 0.1 kilobase pairs (hereinafter "kilo base pair" may be abbreviated as "Kpb"). The restriction enzyme cleavage map of Figure a is shown. The other one has a size of 2.61±0.1 kilobase pairs (Kbp) and shows the restriction enzyme cleavage map shown in Figure b. In Figure a, each restriction position is shown as a positional coordinate with the Hind cleavage site as [0.0/2.57], and the unit is kilobase pair (Kbp). In addition, in Figure b, each restriction site is shown as a position coordinate, with one position of Hind being [0.0/2.61]. Next, the fragments generated by digestion with each restriction enzyme are shown in Table 1 below. In the table, the fragments that appeared densely compared to the size of the fragments were divided into Group A and the others were classified into Group B.

【表】 上記表中(3.3)とあるのは、DNAが1箇所も
切断を受けずオープンリングのままになつてい
て、線状DNAのサイズマーカーに対して見掛け
の分子量が3.3Kbpであることを示している。 上記表における断片DNAのサイズの値は、実
験分析の精度上±0.1Kbp、殊に±0.05Kbpの巾を
持つて変動することがあることを理解すべきであ
る。 制限酵素による分解は、濃度10mM Tris HCl
(PH=7.9)、7mM MgCl2、7mMβ−メルカプト
エタノール、0.01%牛血清アルブミンを基本液と
して行つた。Claによる分解は上記基本液で行
ない、Hind・Ava、Bgl、Kpn、Pvu
による分解は前記基本液にNaClを50mMとなる
ように加え、またSal、BamH、Xba、
Xhoによる分解は前記基本液にNaClを150mM
となるように加えて行つた。 本発明において制限酵素はHind、Sal、
Bgl、BamH、Kpn、Pst、Pvu及び
Xhoの場合はいずれも宝酒造(株)製のものを使用
し、Claの場合はベーリンガー・マンハイム社
製のものを使用し、またAva及びXbaの場合
はベセスダ・リサーチ・ラボラトリーズ社製のも
のを使用した。 本発明においてDNAの切断のための制御酵素
はいずれも少くとも4ユニツト/DNA1μgの割
合で使用し、分解は37℃4時間以上の条件で行つ
た。二種の制限酵素を使用して分解する場合には
先ず低塩濃度用酵素で37℃、2時間以上分解し次
いで高塩濃度に調整し、高塩濃度用の酵素で更に
37℃、2時間以上分解した。 かくして酵素分解後のDNAはエチジウムプロ
マイド0.5μg/mlを含有す1.5%アガロースゲル
電気泳動により各酵素分解によつて生じる断片
DNAの解析を行つた。なおこの電気泳動の際、
DNAのサイズマーカーとしてλ−DNAをEcoR
/Hindで分解したものと、プラスミド
pBR322をTapで分解したものと使用した。 本発明による二本鎖化DNAは、いずれも一本
鎖DNAに対して少くとも部分的に二本鎖化され
ていればよく完全に全領域に亘つて二本鎖化され
ていることは必ずしも必要ではない。 本発明の二本鎖化DNAは例えば植物遺伝子組
み換え用のベクターとして使用されるので、その
ために該DNAを或る酵素によつて切断して使用
される。その場合切断しようとする個所が少くと
も二本鎖化されていさえすれば後のクローニング
化又は増殖によつて二本鎖されていない部位は修
復されほぼ完全に二本鎖化される。従つて本発明
の二本鎖化DNAは少くとも部分的に二本鎖化さ
れていればよいが、望ましくは一本鎖DNAの塩
基対に対して少くとも80%、好ましくは少くとも
90%が二本鎖化されていればよい。aとbの
DNAの割合はBGMVの増殖過程に応じて異つた
値が得られるが、一般にa/b(モル)の比
が3以上を示す。そのために前記表1の如く、A
グループ断片とBグループ断片にグループ分けが
可能である。 本発明の二本鎖化DNA−a及びbは、そ
れぞれ単独又は組合せて植物遺伝子組み換え用の
ベクターとして使用することができる。また
DNAa又はbはその特定の制限部位を制限
酵素で開裂させ線状のDNAとすることが出来る。
このDNAを同じ制限酵素で切り出した第三の
DNAとほぼ同じモル割合で混合し、従来公知の
方法でDNA結合酵素(例えばT4−DNAリガー
ゼ)により結合させa又はbの特定部位に第
三のDNAが入つた環状のDNAとすることが出来
る。 例えば第三のDNAが抗生物質カナマイシに対
して耐性を与える如き遺伝子がコードされている
場合、DNAa又はbに対してこの第三の
DNAを組み込んだDNAを用いることによつて、
植物細胞を形質転換させカナマイシン耐性の細胞
とすることが出来る。この場合の形質転換の方法
としては、例えばプロトプラスト化された植物細
胞にCa++、ポリエチレングリコールの存在下又
はCa++の存在下高PH状態で上記DNAを作用させ
る方法、更に植物細胞の中へ上記DNAを機械的
導入する方法(マイクロインジエクシヨン)など
がある。 また、本発明の二本鎖化DNAa又はbを、
好ましくは或る1箇所で切断し得る酵素、例えば
Hind、Cla又はBglにて分解し、これを同
一制限酵素で開裂した下記の如き他の生物用ベク
ターに組み込むことが出来る。この場合の他の生
物用ベクターとしては、従来公知のもの例えば大
腸菌用のプラスミドベクター(例えばpBR322)、
コスミツドベクター(例えばpKY2662)、フアー
ジベクター(例えばシヤロン10)、枯草菌用のプ
ラスミドベクター(例えばpUB110、pSA0501)、
酵母菌用のベクター(例えばYRp7)などを使用
することが出来る。 これら他の生物用ベクターとのハイブリツド
DNAの調製の方法は、二本鎖化されたDNA−
aとDNA−bの混合物を例えばHindにて完
全に分解しておき、これを他の生物用ベクター例
えば大腸菌用プラスミドpBR322のHind分解物
と混合し、DNA結合酵素(例えばT4−DNAリ
ガーゼ)にて結合環化させることにより
aDNAとpBR322とのハイブリツドDNAを得る
ことが出来る。 また同様に、二本鎖化されたa−DNAと
b−DNAとの混合物をClaで完全分解してお
き、これをpBR322のCla分解物と混合し、
DNA結合酵素にて結合環化させることにより
b−DNAとpBR322とのハイブリツドDNAを得
ることが出来る。 これらハイブリツドDNAを得る際、結合させ
たい2つのDNAはほぼ等モルの割合で混合して
おいて方が、より効率よく目的のハイブリツド
DNAを得ることが出来る。また他の生物用ベク
ターは制限酵素で開裂させた後に、アルカリホス
フアターゼ処理を行ないDNAの5′末端の脱リン
酸反応を行なつておくことは、ハイブリツド
DNAを調製する際に、他の生物用ベクターのみ
で自己環化することを大部分防止できるので好ま
しいことである。 かくして得られたハイブリツドDNAもまた図
a又は図bのDNAと同様に、少くとも部分
的に二本鎖化されたものであり植物遺伝子組み換
え用ベクターとして使用することができる。 このハイブリツドDNAは元の他の生物用ベク
ターの宿主、例えば大腸菌用ベクターとのハイブ
リツドDNAの場合は大腸菌へ、また枯草菌用ベ
クターとのハイブリツドDNAの場合は枯草菌へ、
さらに酵母菌用ベクターとのハイブリツドDNA
の場合は酵母菌へ、公知の方法に従つて例えば大
腸菌や枯草菌の場合は公知の方法により、コンピ
テントセルとなし形質転換し、酵母菌の場合はザ
イモリエス処理してスフエロプラストとなして形
質転換し適当な薬剤耐性又は栄養要求性を使つて
形質転換体を選び出すか又はコロニーハイブリダ
イゼーシヨンを行つて選び出すことが出来る。 この方法の一具体例について更に詳しく説明す
ると例えばハイブリツドDNAが図aのHind
の分解物(bの場合はCla分解物)と大腸菌
プラスミドのpBR322のHind/分解物(bの
場合はCla分解物)とをT4−DNAリガーゼで
結合したハイブリツドDNAである場合、このハ
イブリツドDNAをマンデルとヒガの方法〔J.
Mol.Biol.53 159(1970)参照〕により大腸菌
HB101を形質転換しアンピシリン50μg/mlを含
有する寒天(L−Agar)プレートの上に生じた
コロニーに対し、グルンシユタインとホブネスの
方法〔Proc.Natl.Acad.Sci.72 3961〕によりコ
ロニーハイブリダイゼーシヨンを行ない(この
際、32p−ラベルしたBGMVのDNAをプローブ
として使用する)、32pラベル化したBGMVの
DNAとハイブリダイズするDNAを持つコロニー
を選び出す。この様にして図a(又はb)の
DNAとプラスミドpBR322とがHind(bの
場合はCla)の箇所で結合したハイブリツド
DNAにより形質転換した大腸菌HB101を得るこ
とが出来る。 かくして得られた形質転換体から公知の方法に
よつてハイブリツドDNAを分離することが出来
る。分離されたハイブリツドDNAは全体に亘つ
てほぼ完全に二本鎖化されており、特定の部位に
第三のDNAを組も込み植物細胞を形質変換する
ことが出来、また大腸菌などの菌でも増殖するこ
とが可能である。 目的とするハイブリツドDNAを大量に調製す
るためにハイブリツドDNAを含有する菌株を増
殖させ、必要に応じてハイブリツドDNAのみを
増幅させる操作を行ない菌体を溶菌させ、ハイブ
リツドDNAを含有する水溶液からDNAを分離す
ればよい。ハイブリツドDNAが例えば大腸菌用
のプラスミドpBR322とのハイブリツドDNAで
ある場合には該ハイブリツドDNAを含む大腸菌
形質転換体から例えばマニアテイスらの実験書
「Molecular Cloning−A Laboratory
Manual」〔Cold、psring Harbor Laboratory
(1982)〕第88〜94頁記載の方法によつてハイブリ
ツドDNAの増幅及び各溶菌法を使つてDNAを
得、セシウムクロライドの平衡密度勾配法を用い
コバレントリークローズドサーキユラー(以下、
“ccc”と略す)型のハイブリツドDNAのみを分
離することが可能となる。 また、この様にして分離されたハイブリツド
DNAをクローニングに使用した時と同じ制限酵
素で分解することにより図a(又はb)の
DNA断片とベクターDNA断片とに分けることが
出来る。好ましくは図a(又はb)のDNA断
片を分離し、次にT4−DNAリガーゼなどを用い
て結合環化する。図a(又はb)のDNA断片
のみを分離するには一般にアガロースゲル電気泳
動を行ないa(又はb)のDNA断片のバンド
部分のゲルを切り取り上記マニアテイスからの実
験書の第164〜172頁記載の種々の方法に従つて、
ゲルよりDNA断片を分離し精製することが出来
る。かくして分離されたDNA断片は知られた方
法により、例えばT4−DNAリガーゼを用いて結
合環化し、この際a(又はbのDNAが1個の
みで自己環化したもののほかに2個以上が結合環
化したものが一部形成される。この1個のみが自
己環化したものがアガロースゲル電気泳動にて見
掛け上3.3Kbpのバンドとなる。このバンド部分
のゲルから前述と同様DNAを抽出精製すること
が出来る。このDNAは環全体に亘つて完全に二
本鎖化されており植物遺伝子組み換え用ベクター
として有用である。 次に本発明における複製型DNAについて説明
する。 BGMVが感染増殖している感染葉、例えばト
ツプ・クロツプインゲン(例えばタイキ種苗(株)の
トツプクロツプ)の感染葉よりBGMVの複製型
DNAを分離するにはW.D.O.ハミルトンらの方法
〔Nucl.Acid 5 Res.10 4902(1982)参照〕又
は平井篤志らの著「植物細胞育種入門(学会出版
センター)」第86〜88頁記載の全DNA抽出法を用
いて行うことが出来る。これらの方法に従つて抽
出した全DNAを0.8%アガロースゲル電気泳動を
行つて(この際DNAのサイズマーカーとしてλ
−DNAのEcoR/Hind分解物を一緒に泳動
する)、更にこのゲルよりDNAをニトロセルロー
スフイルターにサザーンを方法〔イー・エム・サ
ザーン・J.Mol.Biol98 503〜517(1975)参照〕
により移動させ32pでラベルした熱変性BGMVの
DNAをプローブに用いてマニイアテイスらの前
記「Molecular Cloning−A Laboratory
Manual」の第387〜389頁記載の方法と同様の操
作でDNA−DNAハイブリダイゼーシヨンを行な
い、次に同著第470〜471頁記載の方法と同様の手
法でオートラジオグラフイーを行う。32pラベル
したBGMVDNAとハイブリダイズするDNA部
分がオートラジオグラフイーで黒いバンドとして
X線フイルム上に現われ、この部分がBGMV由
来のDNAであることを示す。かかるバンドは約
10種類認められ、そのサイズは見掛け上の大きさ
が>20Kbp、9.5Kbp、6.8Kbp、5.2Kbp、
3.8Kbp、3.1Kbp、2.5Kbp、1.9Kbp、1.5Kbp、
0.87Kbpである。これらのバンドを与えるDNA
は色々の形態〔例えばC.C.C.、オーブンサークル
(O.C.)、線状の一量体及び種々の形態の二量体、
三量体など〕を取つているため多種類のバンドに
なつているものと推察される。これらのバンドの
うち、0.87KbpのバンドはBGMVの一本鎖DNA
と一致するが、他は全て二本鎖DNAであり
BGMVの複製型DNAである。 これら複製型中間DNAバンドをアガロースゲ
ルより取り出し、前記と同様の操作によりゲルよ
りDNAのみを分離し、Cla、Hind、Salで
分解すると、いずれも図a,bのDNAを分
解した場合と同じDNA断片を得ることが出来る。
かくすることにより0.87Kbp相当DNA以外の9
種類のバンドを与えるDNAは図a又はbの
DNAを基本とした種々の形態を取つている
BGMVの複製型中間DNAである。これらのバン
ドを与えるDNAのうち1.5Kbp相当部分のDNA、
3.1Kbp相当部分のDNA、9.8Kbp相当部分の
DNAが比較的多量に存在するので利用し易い。 かくして1.5Kbp、3.1Kbp又は9.8Kbp相当分の
DNAをHindで分解し、前述の手段で大腸菌用
プラスミドpBR322のHind部位にクローニング
すると前記同様a−DNA全体を含むハイブリ
ツドDNAを得ることが出来る。また1.5Kbp(又
は3.1Kbp又は9.8Kbp)相当部分のDNAをCla
で分解しpBR322のCla部位にクローニングす
ると前記同様b−DNA全体を含むハイブリツ
ドDNAを得ることが出来る。 クローニングで得たDNAは、しばしばdamメ
チラーゼ遺伝子を持つた大腸菌内で複製させると
特定の塩基配列例えばGATCのAの6位のNが
メチル化され、クローニングで得たDNAでは
元々のDNAの制限酵素部位が見掛け上無くなつ
た様に観察されることがあるが、塩基配列そのも
のは同一である。 またクローニングで得たDNAもウイルスから
直接取り出したDNAと同様にウイルスとして同
じ感染性を有している。 以下実施例を掲げて本発明を詳述するが本発明
はこれらに限定を受けるものではない。 実施例 1 a ウイルスの分離精製 BGMV感染したトツプクロツプ葉57grを250
mlの0.1Mリン酸ナトリウム−10mMEDTAバ
ツフアー(PH=7.8)(システエイン1.3gr含有)
中にて磨砕し二重ガーゼで過し、液を
10000G−40分間4℃にて遠心し205mlの上清を
得た。この上清に食塩2.4g、次いでポリエチ
レングリコール(7800〜9000)8.2grを加
え4℃で1時間撹拌後、10000G25分間、4℃
にて遠心した。上清を除き沈澱したポリエチレ
ングリコールペレツト部に0.1Mリン酸ナトリ
ウムバツフアー(PH=7.8)10mlを加え均一化
し、これを10000G30分間、4℃にて遠心し、
上清を取り出し、この上清をベツクマン社製超
遠心機SW40.1ローターを用いて3万rpm4時間
4℃にて遠心し粗ウイルスを沈澱として得た。
この粗ウイルスを0.5mlの0.1Mリン酸ナトリウ
ムバツフアー(PH=7.8)に均一化した後、10
−40%の連続シヨ糖密度勾配遠心(上記同様の
SW40.1ローターを使用し3.2万rpm3時間4℃)
を行い、遠心後遠心チユーブの底部より0.6ml
づつ分画分取した。各画分の吸光度A260を測定
しフラクシヨンNo.9〜16にウイルスのピークが
見られ、この画分を集め2倍量の0.1Mリン酸
ナトリウムバツフアー(PH=7.8)を加え均一
化して、Sw40.1ローターにて3.5万rpm3時間4
℃でウイルスのペレツトを得、これを0.1Mリ
ン酸ナトリウムバツフアー(PH=7.8)に均一
化し再び10−40%シヨ糖連続密度勾配遠心
(2.9万rpm3時間4℃Sw40.1ローター)し、遠
心チユーブの底部より0.6mlづつ分画分取した。
フラクシヨンNo.13〜18にウイルスピークのみが
得られ、この画分を集め、2倍量の0.1Mリン
酸ナトリウムバツフアー(PH=7.8)を加え均
一化後3.6万rpm3時間半4℃Sw40.1ロータにて
ウイルスを沈澱させ精製BGMVを得た。 b ウイルスより一本鎖DNA遺伝子の分離・
精製 上記精製BGMVに750μの滅菌水、15μの
1MTrisHCl(PH7.6)、75μの10%ドデシル硫
酸ナトリウム(SDS)7.5μのプロテネースK
(1μg/μ液)を加え2分間室温で振盪し次
いで10mMTrisHCl(PH7.6)−1mM EDTA水溶
液で飽和したフエノール700μを加え3分間
振蘯し、エツペンドルフ小型遠心機にて5分間
遠心し水層を取り出した。この水層に同様のフ
エノール抽出操作をさらに2回行い最終的に水
層950μを得、次に水層に対しクロロホルム
700μを加え2分間振盪後、水層を取り出し
この水層にエーテル700μを加えフエノール
を抽出を行う。この抽出操作を3回行つた。得
られた水層1000μに100μの3M酢酸ナトリ
ウムバツフアー(PH4.8)及びエタノール2.5ml
を加え−20℃一昼夜保持し、ベツクマン超遠心
機、Sw50.1ローターにて3.5万rpm20分間遠心
しDNAを沈澱して得た。このDNAを
10mMTrisHCl0.1mMEDTA水溶液600μに
溶解しBGMV一本鎖DNA0.5μg/μ水溶液
とした。 c BGMV一本鎖DNAのin vitro二本鎖化; BGMV一本鎖DNA(0.5μg/μ)2μに
滅菌水155μ、1MTrisHCl(PH=8.0)30μ、
下記の方法により調製された仔牛胸線DNAオ
リゴヌクレオチド(16.6μg/μ)12μを混
合し70℃3分間保持し次いで0℃に急冷後、0
℃の状態に保持しながら、80mMMgCl230μ、
10%β−メルカプトエタノール水溶液30μ、
0.8mMデオキシアデノシン三リン酸、0.8mM
デオキシグアノシン三リン酸及び0.8mMデオ
キシチミジン三リン酸のそれぞれを30μ、
0.8mMデオキシシチジン三リン酸6μ及びデ
オキシシチジン5′−〔α−32p〕三リン酸(アマ
シヤムジヤパン社製約3000Ci/mmol、
10mCi/mlコード番号pB10205)2.4μ及び
AMV逆転写酵素(生化学工業コード120248、
5ユニツト/μ)2μ加え20℃10分間次い
で37℃1時間半反応させた後、フエノール50μ
を加え振盪後エツペンドルフ遠心機にて5分
間遠心し、水層をゲル過した。ゲル過は
10mMTrisHCl(PH7.4)−0.1MNaCl水溶液で予
め平衡化したSephadexG−75(フアルマシアフ
アインケミカル社製)を径6mmの管に5ml充填
したカラムを通して行つた。反応液を乗せた後
4滴(約700μ)づつ分取し、夫々の画分の
32p強度を測定した。画分No.5〜12に最初のピ
ークが現われ、No.15以後に未反応のα−32p−
デオキシシチヂン三リン酸によるピークが認め
られた。画分No.5〜12を集め60μの3MNaCl、
1.8mlのエタノールを加え−20℃3時間保持し
25000rpm20分間(ベツクマン超遠心機Sw50.1
ローター)、遠心し上清を除き、新たに−20℃
冷却した70%エタノール水溶液2mlを加え2万
rpm2分間遠心し上清を除いた。沈殿DNAを20
mmHg1.5分間減圧乾燥した。得られたDNAを
1mMTrisHCl(PH=7.4)−0.1mM EDTA水溶
液100μに溶解し、in vitroで二本鎖化した
DNAを得る。(32pの強度は46×104cpmであつ
た) 仔牛胸腺DNAオリゴヌクレオチドの調製 仔牛胸腺DNA66mgを0.1MNaCl 10mM
MgCl2、10mM TrisHCl(PH7.4)6.6mlに溶解し、
DNase〔ミリポア・コーポレーシヨン社製
(2182ユニツト/g)〕460μgを加え37℃3時間
インキユベートし0.2MEDTA0.66mlを加え反応
させた。この反応液に対し7mlの水飽和フエノー
ルにてタンパク質抽出を3回行い次いで水層から
フエノールを除去するためにエーテル7mlによる
抽出を3回行つた。得られた水層にエタノール20
mlを加え−20℃2時間放置後4000Gで4分間遠心
しDNAペレツトを得た。このDNAペレツトを
0.5mlの0.1MNaCl10mMTrisHCl(PH7.4)に溶解
し、0.1MNaCl 10mMTirsHCl(PH7.4)で予め平
衡化したSephadex G−75(フアルマシア社製)
(カラム長42cm、カラム径0.5cm)によりゲル過
を行い約1.2mlづつ分取した。No.10〜32番のクラ
クシヨンに大きなピークが見られ、No.16〜26の画
分を集め(全量12.5ml)エタノール31mlを加えて
−20℃30分間放置後遠心(4000G8分)して得ら
れるDNAペレツトを1mlの蒸留水に溶解したも
の(DNA濃度16.6mg/ml)をプライマーDNAと
した。 比較例 1 仔牛胸腺DNAオリゴヌクレオチド(16.6μg/
μ)を12μの変わりに1.5μ使用する外は1c
の実験を全く同様の条件で二本鎖化実験を行つた
ところ高分子DNAの部分に32pのカウントは8
×104cpmであつた。1cの場合と比べ1/5以下の二
本鎖化しか起ていないことがわかる。 比較例 2 プライマーをジエイ・エム・テエイラーらの
Biochimica et Biophysica Acta442 325
(1976)の方法で調製した仔牛胸腺DNAからのプ
ライマーミクスチヤー(DNA濃度5μg/μ)
40μを、1c実験のオリゴヌクレオチド(16.6μ
g/μ)12μの変わりに使用し、滅菌水155μ
の変わりに127μ使用し外はすべて1c実験と
全く同様にして二本鎖化を行つた。高分子DNA
部分の32pの強度は15×104cpmであつた。 本比較例2で得られた二本鎖化DNAを後述の
1dの実験と全く同様の条件で制限酵素Cla
Hind、Sal、Bglなどで分解し、以下1dの
実験と全く同様にオートラジオグマフイーまで行
つたところHind分解したものはDNAがアガロ
ースゲルのスロツト位置から全く動いていなかつ
た。またその他の制限酵素で分解したものも、一
部はスロツト位置に止まつており、ゲルの内を泳
動したDNAもかなりスミアとなつて1dの場合程
キレイなバンドではなかつた。 d 制限酵素による二本鎖化DNAの分解・解
折、制限酵素切断地図 cで得た32pラベルした二本鎖DNA(32p
強度46×104cpm/100μ)3μ(32p強度
7300cpm)に対し制限酵素分解用バツフアー
〔100mM TrisHCl(PH7.9)、70mM MgCl2
70mM β−メルカプトエタノール、0.1%牛血
清アルブミンを基本液として、Cla分解はこ
の基本液を制限酵素分解用バツフアーと呼び
Ava、Hind、Bgl、Kpn、Pst、
Pvu分解では上記基本液に更にNaClが
500mMとなるまで添加された液を制限酵素分
解用バツフアーと呼び、またSal、BamH
、Xba、Xho分解では基本液に更に
NaClが1500mMとなる様に添加された液を制
限酵素分解用バツフアーと呼ぶ〕4μ、蒸留
水32μ及び表1の制限酵素Ava(2ユニツ
ト/μ)、BamH(6ユニツト/μ)、
Bgl(6ユニツト/μ)、Pat(5ユニツ
ト/μ)、Xba(6ユニツト/μ)、
Hind(5ユニツト/μ)、Kpn(6ユニ
ツト/μ)、Pvu(6ユニツト/μ)、
Sal(6ユニツト/μ)、Xho(7.5ユニ
ツト/μ)、Cla(5ユニツト/μ)、
〔表1の制限酵素のうちClaはベーリンガー
マンハイム社製Ava、Xbaはベセヌダ・リ
サーチラボラトリー社製、それ以外は宝酒造(株)
製である。〕4ユニツト添加し37℃4時間以上
DNAの分解を行つた。 なお二種の制限酵素で分解する場合は、まず
低塩濃度酵素を添加し、その酵素に適した塩濃
度にて、37℃4時間加水分解し、次により高塩
濃度用酵素に適した塩濃度に調製し、高塩濃度
用酵素を添加して、更に37℃4時間加水分解し
た。加水分解後8μの0.25%ブロモフエノール
ブルー、50%グリセロール、10%SDSの溶液を
加え、65℃5分間熱処理を行い、次に1.5%ア
ガロースゲル電気泳動を行つた。アガロースは
シグマ社のタイプ電気泳動用を使用した。電
気泳動バツフアーとしては40mMトリスアセテ
ート、2mMEDTA(PH8.0)水溶液を用いた。
厚さ5mmの水平ゲルにて1.5V/cmの電圧にて
11〜15時間電気泳動を行つた。この電気泳動の
際、DNA断片のサイズマーカーとしてλ−
DNA0.5μgをEcoR及びHindで完全分解
したもの及びpBR322DNA0.2μgをTapで完
全分解したものを使用した。電気泳動終了後、
アガロースゲルを取り出し、ゲル乾燥板にてア
ガロースゲルを乾燥後、本文記載のマニアテイ
スらの実験書のP470〜472記載の要領にてオー
トラジオグラフイーを実施した。その結果分解
され各種制限酵素により観察されたDNA断片
のサイズを記すと本文表1の様になつた。 尚、オートラジオグラフイー後、観察された
DNA断片は、その断片の大きさに比べ濃く出
る断片群をAグループに、また断片の大きさに
比べ淡く出る断片群をBグループに分類して記
した。 また、括弧内の3.3は、DNAがオープンサー
クル(O.C.)の状態で、線状のDNAサイズマ
ーカーに対し見掛け上の分子量が3.3Kbpであ
る如くを示している。この表よりA群の断片を
生ずるDNAは制限酵素分解する前はオープン
サークル(O.C.)状で大きさが約2.57Kbpと考
えられる。尚、この正確な大きさは最終的には
塩基配列を決定することにより知り得るが、現
方法にては、測定誤差として最小0.05Kbpは避
けられない。A群断片を生ずるDNAの大きさ
は2.57±0.1Kbp程度と記載され得る同様の考察
からB群の断片を生ずるDNAは制限酵素分解
する前はO.C状で大きさが(2.61±0.1)Kbpと
記載される。 次に各種制限酵素単独による分解、及び二種
の組み合わせによる分解、これらの分解パター
ンを分析することにより、各種制限酵素切断点
の相対位置関係が決定され、A群のDNA断片
を生ずる無傷のDNAについての制限酵素切断
地図として本文図aが得られ、B群のDNA
について無傷DNAについての制限酵素切断地
図として本文図bが得られる。 e 二本鎖化DNAのHind分解物と大腸菌用
プラスミドpBR322とのハイブリツドDNA; 実施例cで得られた二本鎖化DNA100μ
溶液のうち50μを、予め10mMTrisHCl(PH
7.4)、100mMNaCl水溶液で平衡化したBiogel
P30を径6mm、長さ30cmに充填したカラムに
て、ゲル過を行つた。溶出液として
10mMTrisHCl(PH7.4)、100mMNaCl水溶液を
使い、4滴(約400μ)づつ分取した。第17
〜21画分に32pの高いカウントのピークが見ら
れ、分画液の光学密度OD260を測定したら第28
画分からODの値が増加し始め以後の画分では
大きな値を示した。二本鎖化DNAの部分であ
る第17〜21画分を集め(2.1ml)、これに3M酢
酸ナトリウム水溶液(PH4.8)200μ及びエタ
ノール4mlを加え−20℃2時間保持後ベツクマ
ン超遠心機Sw50.1ローターにて30000rpm30分
間遠心した。上清を捨て、新たに−20℃75%エ
タノール5mlを加え20000rpm2分間遠心し、再
び上清を捨てDNAペレツトを得た。2mmHg2
分間真空乾燥後、このDNAペレツトを蒸留水
50μに溶解しこのDNA溶液50μに対し、前
記制限酵素Hind分解用バツフアー(実施例
c既述)6μ及び制限酵素Hind3μを加
え37℃4時間反応させた。次に10μの酵母
tRNA(2μg/μ)溶液及び熟留水70μを加
え、更に水飽和フエノール100μを加え振盪
後遠心して水層のみを取り出し、この水層から
エーテル抽出3回によりフエノールを取り除い
た。 3Mの酢酸ナトリウム(PH=4.8)10μ及び
エタノール350μ加え−20℃4時間放置後高
速遠心し得られたDNAペレツトを乾燥後17μ
の蒸留水に溶解した。 このDNA17μ溶液に対し下記に示す
pBR322のHind/アルカリホスフアターゼ処
理(DNA1μg/μ)液1μ及びDNA結合
酵素用バツフアー〔650mMTrisHCl(PH=
7.4)、65mMMgCl、10mMDTT、4mMATP、
40mMSpermide水溶液〕2μ及びT4DNAリ
ガーゼ(宝酒造社製コードNo.2010B1.2ユニツ
ト/μ)0.5μを加え14℃22時間反応させ、
次に65℃5分間処理を行いハイブリツドDNA
を得る。 次にこのハイブリツドDNAを用いて大腸菌
HB101のコンビテントセルを形質転換する。 pBR322のBamH/アルカリホスフアターゼ
処理液; pBR322のHind/アルカリホスフアターゼ処
理(DNA1μg/μ)液プラスミド
pBR322DNA50μgを含む340μ水溶液に前記
Hind制限酵素用バツフアー40μ及びHind
20μを加え37℃10時間反応後1MTrisHCl(PH
8.0)を44μ加え、バクテリアアルカラインホス
フアターゼ(BAP)(worthington社製0.4ユニツ
ト/μ)10μ加え65℃7時間処理した。この
反応によりDNAの5′末端が脱リン酸化される。
この反応液に対し水飽和フエノール400μにて
除タンパクを行すた。次いでフエノール/クロロ
ホルム(4/1容積比)混合液400μで2回、更に
除タンパクを行い、最後に600μのエーテルに
て3回水溶液からフエノール成分抽出を行つた。 水層350μに3M酢酸ナトリウム30μ、エタ
ノール110μを加え−20℃2時間放置後高速遠
心し、得られたDNApelletを乾燥後50μの蒸留
水に溶解した。これをpBR322のHind/アルカ
リホスフアターゼ処理(DNA1μg/μ)液と
する。 大腸菌HB101のコンピテントセルの調製及び
その形質転換; 大腸菌HB101のシングルコロニーを培養液L
−broth5mlに移し37℃11時間振盪培養した。この
2mlを新しいL−broth200mlに接種し、37℃2時
間20分振盪培養しOD600が0.40となつた時点で、
培養液を0℃に冷却し、トミーの冷却高速遠心機
No.9ローターにて5000rpm5分間遠心した。上清
は捨て、沈殿した大腸菌を50mlの10mMNaCl水
に均質に分散させ、再び高速遠心(No.4ロータ
ー、5000rpm5分間)し菌を沈殿させこの菌ペレ
ツトに60mlの30mMCaCl2水を加え全体を均質化
0℃で20分間保持した。 再び高速遠心(No.4ローター、4000rpm5分間)
し上清を捨て菌ペレツトに10mlの30mMCaCl2
15%グリセロール水溶液を加え緩やかに全体を均
質化し、200μづつ1.5mlのエツペンドルフチユ
ーブに分注し、−80℃に凍結保存する。この
CaCl2処理した大腸菌HB101を、(コンピテント
セルと呼び)形質転換した。形質転換はこのコン
ピテントセルを0℃に戻し、10分位後に前記の
T4DNAリガーゼにて結合反応を行い次に65℃5
分間処理を行つたハイブリツドDNA水溶液を加
え、0℃40分間保持し、次いで42℃2分間加温し
た。次にL−broth1.5mlを加え37℃1時間保持
し、この培養液をアンピシリン50μ/ml含有す
るL−agarプレート(直径9cm)8枚に1枚当
り約200μづつ撒き拡げた。37℃16時間保持し
41ケの形質転換したHB101のコロニーを得た。
この41ケのコロニーを前記マニアテイスらの実験
書P368記載のBoiling Lysis法によりプラスミド
DNAのミニ調製を行い、次にプラスミドDNAを
Hind分解した。その結果2.58Kbp、1.62Kbp、
1.02Kbpを含むプラスミドを得た。2.58Kbpは図
aのDNAがHind開裂したもの、1.62Kbp及
び1.02Kbpは図bのDNAがHindで分解して
生ずる2種の断片であつた。2.58Kbp断片と
pBR322とのハイブリツドDNAをpBGH1、
1.6NKbp断片とpBR322とのハイブリツドDNA
をpBGH29 1.02KbpとpBR322とのハイブリツド
DNAをpBGH4とした。pBGH1のDNAは
pBR322の宿主大腸菌の内で複製増殖したもので
DNA全体に亘つて完全に二本鎖化していた。ハ
イブリツドDNApBGH1をHind/Bgl、
Hind/Ava、Hind/Sal/Cla、Hind
/Bgl/Ava、Hind/Cla/Bglで
完全分解し、1.2%アガロースゲル電気泳動を行
い(同時にサイズマーカーとしてλDNAのEcoR
/Hind分解物、及びpBR322のTap分解物
も泳動)、DNAの断片サイズを解析し表2の結果
を得た。
[Table] In the table above, (3.3) means that the DNA remains as an open ring without being cut at any point, and the apparent molecular weight is 3.3 Kbp relative to the size marker of linear DNA. It shows. It should be understood that the values for the size of fragment DNA in the table above may vary by ±0.1 Kbp, especially ±0.05 Kbp due to the accuracy of experimental analysis. For restriction enzyme digestion, use a concentration of 10mM Tris HCl.
(PH=7.9), 7mM MgCl 2 , 7mM β-mercaptoethanol, and 0.01% bovine serum albumin were used as the base solution. Decomposition with Cla is performed with the above basic solution, Hind, Ava, Bgl, Kpn, Pvu
For the decomposition, NaCl was added to the base solution to a concentration of 50mM, and Sal, BamH, Xba,
For Xho decomposition, add 150mM NaCl to the base solution.
I added it so that In the present invention, restriction enzymes include Hind, Sal,
Bgl, BamH, Kpn, Pst, Pvu and
For Xho, we use products manufactured by Takara Shuzo Co., Ltd., for Cla, we use products manufactured by Boehringer Mannheim, and for Ava and Xba, we use products manufactured by Bethesda Research Laboratories. did. In the present invention, all control enzymes for DNA cleavage were used at a ratio of at least 4 units/1 μg of DNA, and the digestion was carried out at 37° C. for 4 hours or more. When using two types of restriction enzymes, first digest with a low salt concentration enzyme at 37℃ for 2 hours or more, then adjust to a high salt concentration, and further with a high salt concentration enzyme.
Decomposed at 37°C for over 2 hours. Thus, the DNA after enzymatic degradation was analyzed by electrophoresis on a 1.5% agarose gel containing 0.5 μg/ml of ethidium bromide to identify the fragments generated by each enzymatic degradation.
We conducted DNA analysis. In addition, during this electrophoresis,
EcoR of λ-DNA as a DNA size marker
/Hind digested product and plasmid
pBR322 was digested with Tap and used. The double-stranded DNA according to the present invention only needs to be at least partially double-stranded compared to the single-stranded DNA, and is not necessarily double-stranded over the entire region. Not necessary. Since the double-stranded DNA of the present invention is used, for example, as a vector for plant genetic recombination, the DNA is used after being cut with a certain enzyme. In that case, as long as the site to be cut is at least double-stranded, the non-double-stranded site will be repaired and almost completely double-stranded by subsequent cloning or propagation. Therefore, the double-stranded DNA of the present invention only needs to be at least partially double-stranded, but desirably at least 80% of the base pairs of single-stranded DNA, preferably at least
It is sufficient that 90% of the chain is double-stranded. a and b
Different values of the DNA ratio can be obtained depending on the growth process of BGMV, but generally the a/b (mole) ratio is 3 or more. Therefore, as shown in Table 1 above, A
Grouping is possible into group fragments and B group fragments. Double-stranded DNA-a and b of the present invention can be used alone or in combination as a vector for plant genetic recombination. Also
DNA a or b can be cleaved at a specific restriction site with a restriction enzyme to form linear DNA.
A third cut of this DNA using the same restriction enzyme
It can be mixed with DNA in approximately the same molar ratio and linked using a DNA binding enzyme (e.g. T4-DNA ligase) using a conventionally known method to form a circular DNA containing a third DNA at a specific site of a or b. . For example, if the third DNA encodes a gene that confers resistance to the antibiotic Kanamaishi, this third DNA
By using DNA that incorporates DNA,
Plant cells can be transformed to become kanamycin resistant. In this case, transformation methods include, for example, a method in which the above-mentioned DNA is applied to protoplast-formed plant cells in the presence of Ca ++ , polyethylene glycol, or in the presence of Ca ++ in a high pH state; There is a method of mechanically introducing the above-mentioned DNA into a cell (microinjection). Moreover, the double-stranded DNA a or b of the present invention,
Preferably an enzyme capable of cleaving at one site, e.g.
It can be digested with Hind, Cla or Bgl and then inserted into other biological vectors cleaved with the same restriction enzymes as shown below. In this case, other biological vectors include conventionally known vectors such as plasmid vectors for E. coli (e.g. pBR322),
cosmid vectors (e.g. pKY2662), phage vectors (e.g. Syaron 10), plasmid vectors for Bacillus subtilis (e.g. pUB110, pSA0501),
Vectors for yeast (eg, YRp7) can be used. Hybrids with these other biological vectors
The method for preparing DNA consists of double-stranded DNA-
A mixture of a and DNA-b is completely digested using, for example, Hind, and this is mixed with a Hind-digested product of other biological vectors, such as plasmid pBR322 for E. coli, and treated with a DNA-binding enzyme (e.g., T4-DNA ligase). By cyclizing the bond with
Hybrid DNA of aDNA and pBR322 can be obtained. Similarly, a mixture of double-stranded a-DNA and b-DNA is completely degraded with Cla, and this is mixed with the Cla-digested product of pBR322,
Hybrid DNA of b-DNA and pBR322 can be obtained by cyclization using a DNA binding enzyme. When obtaining these hybrid DNAs, it is better to mix the two DNAs you want to combine in approximately equimolar proportions to more efficiently produce the desired hybrid DNA.
DNA can be obtained. In addition, for other biological vectors, it is recommended to dephosphorylate the 5′ end of the DNA by treating with alkaline phosphatase after cleavage with restriction enzymes.
This is preferable because when preparing DNA, self-circularization can be largely prevented by using vectors for other organisms alone. The hybrid DNA thus obtained is also at least partially double-stranded, like the DNA in Figure a or Figure b, and can be used as a vector for plant genetic recombination. This hybrid DNA is transferred to the original host of other biological vectors, such as E. coli in the case of a hybrid DNA with a vector for E. coli, and Bacillus subtilis in the case of a hybrid DNA with a vector for Bacillus subtilis.
Furthermore, hybrid DNA with yeast vector
In the case of yeast, for example, Escherichia coli and Bacillus subtilis are transformed into competent cells according to known methods, and in the case of yeast, they are treated with Zymolys to form spheroplasts. Transformants can be transformed and selected using appropriate drug resistance or auxotrophy, or by colony hybridization. To explain in more detail one specific example of this method, for example, hybrid DNA is Hind in Figure a.
If the hybrid DNA is a hybrid DNA obtained by ligating a degraded product (Cla degraded product in the case of b) with a Hind/digested product of E. coli plasmid pBR322 (Cla degraded product in the case of b) using T4-DNA ligase, this hybrid DNA is Mandel and Higa's method [J.
Mol. Biol. 53 159 (1970)]
HB101 was transformed and colonies generated on agar (L-Agar) plates containing 50 μg/ml ampicillin were subjected to colony hybridization using the method of Grunstein and Hovnes [Proc. Natl. Acad. Sci. 72 3961]. (At this time, 32p-labeled BGMV DNA is used as a probe).
Select colonies with DNA that hybridizes with the DNA. In this way, figure a (or b)
A hybrid in which DNA and plasmid pBR322 are joined at Hind (Cla in case of b)
Escherichia coli HB101 transformed with DNA can be obtained. Hybrid DNA can be isolated from the transformant thus obtained by a known method. The isolated hybrid DNA is almost completely double-stranded throughout, and it is possible to transform plant cells by inserting a third DNA into a specific site, and it can also be grown in bacteria such as Escherichia coli. It is possible to do so. In order to prepare a large amount of the desired hybrid DNA, a bacterial strain containing the hybrid DNA is grown, and if necessary, operations are performed to amplify only the hybrid DNA to lyse the bacterial cells, and the DNA is extracted from the aqueous solution containing the hybrid DNA. Just separate it. When the hybrid DNA is, for example, a hybrid DNA with the plasmid pBR322 for E. coli, an E. coli transformant containing the hybrid DNA is used, for example, in the experimental book "Molecular Cloning-A Laboratory" by Maniatis et al.
Manual”〔Cold, psring Harbor Laboratory
(1982)] using the methods described on pages 88 to 94 to obtain DNA using amplification of hybrid DNA and various lysis methods, and using a covalently closed cycle (hereinafter referred to as
This makes it possible to separate only hybrid DNA of the type (abbreviated as “ccc”). In addition, the hybrid isolated in this way
Figure a (or b) can be obtained by digesting the DNA with the same restriction enzyme used for cloning.
It can be divided into DNA fragments and vector DNA fragments. Preferably, the DNA fragment shown in Figure a (or b) is separated and then ligated and circularized using T4-DNA ligase or the like. To separate only the DNA fragment shown in figure a (or b), generally agarose gel electrophoresis is performed, and the band portion of the DNA fragment shown in a (or b) is cut out from the gel, as described on pages 164 to 172 of the experimental book from Maniatis mentioned above. According to various methods of
DNA fragments can be separated and purified using gel. The DNA fragments thus separated are combined and circularized using a known method, for example, using T4-DNA ligase. A part of the circularized substance is formed. This single self-circularized substance becomes an apparent 3.3 Kbp band in agarose gel electrophoresis. DNA is extracted and purified from this banded gel in the same manner as described above. This DNA is completely double-stranded throughout the ring and is useful as a vector for plant genetic recombination. Next, the replicative DNA in the present invention will be explained. When BGMV infects and proliferates, The replication type of BGMV is detected from the infected leaves of infected leaves, such as top crop beans (for example, top crop of Taiki Seed Co., Ltd.).
To isolate DNA, use the method of WDO Hamilton et al. [Refer to Nucl. Acid 5 Res. 10 4902 (1982)] or the entire method described in "Introduction to Plant Cell Breeding (Gakkai Publishing Center)" by Atsushi Hirai et al., pp. 86-88. This can be done using a DNA extraction method. Total DNA extracted according to these methods was subjected to 0.8% agarose gel electrophoresis (at this time, λ was used as a DNA size marker).
-EcoR/Hind degradation products of DNA are run together), and then the DNA is transferred from this gel to a nitrocellulose filter (see E.M. Southern, J.Mol.Biol 98, 503-517 (1975)).
of heat-denatured BGMV transferred and labeled with 32p.
Using DNA as a probe, Maniaiatis et al.'s ``Molecular Cloning-A Laboratory''
DNA-DNA hybridization is carried out in the same manner as described on pages 387 to 389 of the same book, and then autoradiography is carried out in the same manner as described on pages 470 to 471 of the same book. The DNA portion that hybridizes with the 32p-labeled BGMV DNA appears as a black band on the X-ray film during autoradiography, indicating that this portion is BGMV-derived DNA. This band is approx.
Ten types are recognized, and their apparent sizes are >20Kbp, 9.5Kbp, 6.8Kbp, 5.2Kbp,
3.8Kbp, 3.1Kbp, 2.5Kbp, 1.9Kbp, 1.5Kbp,
It is 0.87Kbp. DNA that gives these bands
can be present in various forms [e.g. CCC, oven circle (OC), linear monomers and dimers of various forms,
It is inferred that the band is composed of many different types of bands, such as trimers. Among these bands, the 0.87Kbp band is the single-stranded DNA of BGMV.
, but all others are double-stranded DNA.
This is the replicative DNA of BGMV. These replicative intermediate DNA bands are removed from the agarose gel, and only the DNA is separated from the gel using the same procedure as above, and when digested with Cla, Hind, and Sal, the same DNA as in Figures a and b is obtained. You can get fragments.
By doing this, 9 other than DNA equivalent to 0.87Kbp
The DNA that gives each type of band is shown in figure a or b.
It takes various forms based on DNA.
This is the replicative intermediate DNA of BGMV. A portion of the DNA that gives these bands, equivalent to 1.5 Kbp,
DNA equivalent to 3.1Kbp, DNA equivalent to 9.8Kbp
Since DNA is present in relatively large amounts, it is easy to use. Thus, the equivalent of 1.5Kbp, 3.1Kbp or 9.8Kbp
By digesting the DNA with Hind and cloning it into the Hind site of the E. coli plasmid pBR322 using the method described above, a hybrid DNA containing the entire a-DNA can be obtained as described above. In addition, 1.5Kbp (or 3.1Kbp or 9.8Kbp) of DNA was
By degrading the b-DNA and cloning it into the Cla site of pBR322, a hybrid DNA containing the entire b-DNA can be obtained as described above. When DNA obtained by cloning is replicated in E. coli that has a dam methylase gene, certain base sequences, for example, the N at position 6 of A in GATC, are methylated, and in the DNA obtained by cloning, the restriction enzyme of the original DNA is methylated. Although it may be observed that the site appears to have disappeared, the base sequence itself is the same. Furthermore, DNA obtained through cloning has the same infectivity as a virus, just like DNA extracted directly from a virus. The present invention will be described in detail below with reference to Examples, but the present invention is not limited thereto. Example 1 a Virus isolation and purification 57gr of BGMV-infected top crop leaves were collected at 250g.
ml of 0.1M sodium phosphate - 10mM MEDTA buffer (PH=7.8) (contains 1.3gr of cysteine)
Grind the mixture, filter it through double gauze, and drain the liquid.
Centrifugation was performed at 10,000G for 40 minutes at 4°C to obtain 205ml of supernatant. To this supernatant, add 2.4g of salt, then 8.2g of polyethylene glycol (7800-9000), stir at 4℃ for 1 hour, and then apply 10000G for 25 minutes at 4℃.
It was centrifuged at After removing the supernatant, 10 ml of 0.1 M sodium phosphate buffer (PH = 7.8) was added to the precipitated polyethylene glycol pellet to homogenize it, and this was centrifuged at 10,000 G for 30 minutes at 4°C.
The supernatant was removed, and the supernatant was centrifuged at 4° C. for 4 hours at 30,000 rpm using an ultracentrifuge SW40.1 rotor manufactured by Beckman to obtain a crude virus as a precipitate.
After homogenizing this crude virus in 0.5 ml of 0.1 M sodium phosphate buffer (PH = 7.8),
−40% continuous sucrose density gradient centrifugation (same as above)
Using SW40.1 rotor, 32,000 rpm 3 hours 4℃)
After centrifugation, extract 0.6ml from the bottom of the centrifuge tube.
Fractions were collected one by one. The absorbance A260 of each fraction was measured, and virus peaks were observed in fractions No. 9 to 16. These fractions were collected and homogenized by adding twice the amount of 0.1M sodium phosphate buffer (PH = 7.8). , 35,000 rpm 3 hours 4 with Sw40.1 rotor
A virus pellet was obtained at °C, homogenized in 0.1M sodium phosphate buffer (PH = 7.8), and again subjected to 10-40% sucrose continuous density gradient centrifugation (29,000 rpm 3 hours at 4 °C Sw40.1 rotor). A fraction of 0.6 ml was collected from the bottom of the centrifuge tube.
Only virus peaks were obtained in fractions No. 13 to 18. These fractions were collected, and after homogenization by adding twice the amount of 0.1M sodium phosphate buffer (PH = 7.8), they were heated at 36,000 rpm for 3 and a half hours at 4°C Sw40. The virus was precipitated using one rotor to obtain purified BGMV. b Isolation of single-stranded DNA genes from viruses
Purification Add 750μ of sterile water and 15μ of the purified BGMV above.
1MTrisHCl (PH7.6), 75μ 10% Sodium Dodecyl Sulfate (SDS) 7.5μ Proteinase K
(1μg/μ solution) was added and shaken at room temperature for 2 minutes, then 700μ of phenol saturated with 10mM TrisHCl (PH7.6)-1mM EDTA aqueous solution was added, shaken for 3 minutes, and centrifuged for 5 minutes in an Etzpendorf small centrifuge to remove the aqueous layer. I took it out. This aqueous layer was subjected to the same phenol extraction procedure twice more to obtain a final aqueous layer of 950μ, and then the aqueous layer was extracted with chloroform.
After adding 700μ of ether and shaking for 2 minutes, remove the aqueous layer and add 700μ of ether to extract the phenol. This extraction operation was performed three times. Add 100μ of 3M sodium acetate buffer (PH4.8) and 2.5ml of ethanol to 1000μ of the resulting aqueous layer.
was added and kept at -20°C overnight, and centrifuged for 20 minutes at 35,000 rpm in a Beckman ultracentrifuge with a Sw50.1 rotor to precipitate DNA. This DNA
It was dissolved in 600μ of an aqueous solution of 10mM TrisHCl and 0.1mM EDTA to obtain a 0.5μg/μ aqueous solution of BGMV single-stranded DNA. c In vitro duplexing of BGMV single-stranded DNA; 2μ of BGMV single-stranded DNA (0.5μg/μ), 155μ of sterile water, 30μ of 1M TrisHCl (PH=8.0),
Mix 12μ of calf thymus DNA oligonucleotide (16.6μg/μ) prepared by the method below, hold at 70℃ for 3 minutes, then rapidly cool to 0℃,
30μ of 80mM MgCl, while keeping at °C.
10% β-mercaptoethanol aqueous solution 30μ,
0.8mM deoxyadenosine triphosphate, 0.8mM
30μ each of deoxyguanosine triphosphate and 0.8mM deoxythymidine triphosphate;
0.8mM deoxycytidine triphosphate 6 μ and deoxycytidine 5′-[α-32p] triphosphate (approximately 3000 Ci/mmol manufactured by Amashiyam Japan Co., Ltd.,
10mCi/ml code number pB10205) 2.4μ and
AMV reverse transcriptase (Seikagaku code 120248,
After adding 2μ of phenol (5 units/μ) and reacting for 10 minutes at 20℃ and 1.5 hours at 37℃, 50μ of phenol was added.
After shaking, the mixture was centrifuged for 5 minutes using an Etzpendorf centrifuge, and the aqueous layer was filtered through a gel. Gel filter
Sephadex G-75 (manufactured by Pharmacia Fine Chemical Co., Ltd.) equilibrated in advance with a 10mM TrisHCl (PH7.4)-0.1M NaCl aqueous solution was passed through a column packed in a 6mm diameter tube with 5ml. After adding the reaction solution, separate 4 drops (approximately 700μ) and separate each fraction.
32p intensity was measured. The first peak appears in fractions No. 5 to 12, and unreacted α-32p-
A peak due to deoxycytidine triphosphate was observed. Collect fractions No. 5 to 12 and add 60μ of 3M NaCl.
Add 1.8ml of ethanol and hold at -20℃ for 3 hours.
25000rpm for 20 minutes (Betskuman ultracentrifuge Sw50.1
rotor), centrifuge, remove the supernatant, and store at -20°C.
Add 2 ml of cooled 70% ethanol aqueous solution to 20,000 ml.
The mixture was centrifuged at rpm for 2 minutes and the supernatant was removed. Precipitate DNA 20
Dry under reduced pressure of mmHg for 1.5 minutes. The obtained DNA
Dissolved in 100μ of 1mM TrisHCl (PH = 7.4) - 0.1mM EDTA aqueous solution and double-stranded in vitro.
Get DNA. (The intensity of 32p was 46×10 4 cpm) Preparation of calf thymus DNA oligonucleotide 66 mg of calf thymus DNA was added to 0.1M NaCl 10mM.
MgCl2 , dissolved in 6.6ml of 10mM TrisHCl (PH7.4),
460 μg of DNase (manufactured by Millipore Corporation (2182 units/g)) was added, incubated at 37° C. for 3 hours, and 0.66 ml of 0.2 MEDTA was added to react. This reaction solution was subjected to protein extraction three times with 7 ml of water-saturated phenol, and then extracted three times with 7 ml of ether to remove phenol from the aqueous layer. Add 20% ethanol to the resulting aqueous layer.
ml was added, left at -20°C for 2 hours, and centrifuged at 4000G for 4 minutes to obtain a DNA pellet. This DNA pellet
Sephadex G-75 (manufactured by Pharmacia) dissolved in 0.5 ml of 0.1M NaCl 10mM TrisHCl (PH7.4) and pre-equilibrated with 0.1M NaCl 10mM TirsHCl (PH7.4)
(column length: 42 cm, column diameter: 0.5 cm) and aliquots of approximately 1.2 ml were collected. A large peak was observed in the crackles No. 10 to 32, and the fractions No. 16 to 26 were collected (total volume 12.5 ml), 31 ml of ethanol was added, left at -20°C for 30 minutes, and then centrifuged (4000G for 8 minutes). The resulting DNA pellet was dissolved in 1 ml of distilled water (DNA concentration 16.6 mg/ml) and used as primer DNA. Comparative example 1 Calf thymus DNA oligonucleotide (16.6μg/
μ) is 1.5μ instead of 12μ, otherwise it is 1c
When a double-stranded experiment was conducted under exactly the same conditions as the above experiment, the count of 32p in the polymeric DNA part was 8.
×10 4 cpm. It can be seen that less than 1/5 of the double stranding has occurred compared to 1c. Comparative Example 2 The primer was prepared by G.M. Theiler et al.
Biochimica et Biophysica Acta 442 325
Primer mixture from calf thymus DNA prepared by the method of (1976) (DNA concentration 5 μg/μ)
40μ, the oligonucleotide for the 1c experiment (16.6μ
g/μ) Used instead of 12μ, sterile water 155μ
Double stranding was performed in exactly the same manner as in the 1c experiment, except that 127μ was used instead of 1c. polymer DNA
The 32p intensity of the part was 15×10 4 cpm. The double-stranded DNA obtained in Comparative Example 2 was
restriction enzyme Cla under exactly the same conditions as in experiment 1d.
When the DNA was digested with Hind, Sal, Bgl, etc. and then subjected to autoradiography in exactly the same manner as in experiment 1d below, the DNA of the Hind-digested DNA had not moved from the slot position of the agarose gel. In addition, some of the DNA digested with other restriction enzymes remained in the slot position, and the DNA that migrated through the gel also became quite smeared, and the bands were not as beautiful as in the case of 1d. d Degradation and disassembly of double-stranded DNA using restriction enzymes, restriction enzyme cleavage map 32p-labeled double-stranded DNA (32p
Strength 46× 104 cpm/100μ) 3μ (32p strength
7300 cpm) and buffer for restriction enzyme digestion [100mM TrisHCl (PH7.9), 70mM MgCl 2 ,
For Cla decomposition, use 70mM β-mercaptoethanol and 0.1% bovine serum albumin as the base solution.This base solution is called the buffer for restriction enzyme digestion.
Ava, Hind, Bgl, Kpn, Pst,
In Pvu decomposition, NaCl is added to the above basic solution.
The solution added to 500mM is called restriction enzyme digestion buffer, and Sal, BamH
, Xba, and Xho decomposition, the basic solution is further
A solution containing 1500mM NaCl is called a restriction enzyme digestion buffer] 4μ, distilled water 32μ, and the restriction enzymes Ava (2 units/μ) and BamH (6 units/μ) shown in Table 1.
Bgl (6 units/μ), Pat (5 units/μ), Xba (6 units/μ),
Hind (5 units/μ), Kpn (6 units/μ), Pvu (6 units/μ),
Sal (6 units/μ), Xho (7.5 units/μ), Cla (5 units/μ),
[Among the restriction enzymes in Table 1, Cla is Ava manufactured by Boehringer Mannheim, Xba is manufactured by Bethenuda Research Laboratory, and the others are Takara Shuzo Co., Ltd.
Made in Japan. ]4 units added and heated at 37℃ for over 4 hours
DNA was degraded. When decomposing with two types of restriction enzymes, first add a low-salt concentration enzyme, hydrolyze for 4 hours at 37℃ at a salt concentration suitable for the enzyme, and then add a salt suitable for a high-salt concentration enzyme. After adjusting the concentration, an enzyme for high salt concentration was added, and further hydrolysis was carried out at 37°C for 4 hours. After hydrolysis, 8μ of a solution of 0.25% bromophenol blue, 50% glycerol, and 10% SDS was added, heat treated at 65°C for 5 minutes, and then 1.5% agarose gel electrophoresis was performed. The agarose used was for type electrophoresis manufactured by Sigma. A 40mM Tris acetate, 2mM MEDTA (PH8.0) aqueous solution was used as an electrophoresis buffer.
At a voltage of 1.5 V/cm in a horizontal gel with a thickness of 5 mm
Electrophoresis was performed for 11-15 hours. During this electrophoresis, λ-
0.5 μg of DNA was completely digested with EcoR and Hind, and 0.2 μg of pBR322 DNA was completely digested with Tap. After electrophoresis,
The agarose gel was taken out, and after drying on a gel drying plate, autoradiography was performed as described in pages 470 to 472 of the experimental book by Maniathes et al. described in the main text. As a result, the sizes of DNA fragments degraded and observed with various restriction enzymes are shown in Table 1 of the text. Furthermore, after autoradiography, it was observed that
The DNA fragments were classified into Group A, which is a group of fragments that appear more densely compared to the size of the fragment, and Group B, which is a group of fragments that appear lighter compared to the size of the fragment. Furthermore, 3.3 in parentheses indicates that the DNA is in an open circle (OC) state and the apparent molecular weight is 3.3 Kbp relative to the linear DNA size marker. From this table, it is thought that the DNA that produces the fragments of group A is open circle (OC) shaped and approximately 2.57 Kbp in size before being digested with restriction enzymes. The exact size can ultimately be determined by determining the base sequence, but with the current method, a minimum measurement error of 0.05 Kbp is unavoidable. The size of the DNA that produces group A fragments can be described as approximately 2.57±0.1 Kbp.From the same consideration, the DNA that produces group B fragments is OC-shaped and has a size of (2.61±0.1) Kbp before being digested with restriction enzymes. be written. Next, by analyzing the degradation patterns of various restriction enzymes alone and in combination, the relative positional relationships of the various restriction enzyme cleavage points are determined, and the intact DNA that produces Group A DNA fragments is determined. Figure a in the text is obtained as a restriction enzyme cleavage map for DNA of group B.
Figure b in the text is obtained as a restriction enzyme cleavage map for intact DNA. e Hybrid DNA of Hind-digested double-stranded DNA and plasmid pBR322 for E. coli; 100μ of double-stranded DNA obtained in Example c
50μ of the solution was pre-mixed with 10mM TrisHCl (PH
7.4), Biogel equilibrated with 100mM NaCl aqueous solution
Gel filtration was performed using a column packed with P30 to a diameter of 6 mm and a length of 30 cm. as eluent
Using 10mM TrisHCl (PH7.4) and 100mM NaCl aqueous solution, 4 drops (approximately 400μ) were collected. 17th
A high count peak of 32p was seen in the ~21 fraction, and when the optical density OD 260 of the fraction was measured, the 28th
The OD value started to increase from the fractions and showed large values in the subsequent fractions. Collect fractions 17 to 21 (double-stranded DNA) (2.1 ml), add 200μ of 3M sodium acetate aqueous solution (PH4.8) and 4 ml of ethanol, hold at -20°C for 2 hours, and then centrifuge in a Beckman ultracentrifuge. Centrifugation was performed at 30,000 rpm for 30 minutes in a Sw50.1 rotor. The supernatant was discarded, 5 ml of 75% ethanol at -20°C was added, and the mixture was centrifuged at 20,000 rpm for 2 minutes, and the supernatant was discarded again to obtain a DNA pellet. 2mmHg2
After vacuum drying for a minute, the DNA pellet was washed with distilled water.
To 50μ of this DNA solution, 6μ of the aforementioned restriction enzyme Hind digestion buffer (described in Example C) and 3μ of restriction enzyme Hind were added and reacted at 37°C for 4 hours. Then 10μ yeast
A tRNA (2 μg/μ) solution and 70 μl of distilled water were added, and 100 μl of water-saturated phenol was added, followed by shaking and centrifugation to remove only the aqueous layer. From this aqueous layer, ether extraction was performed three times to remove phenol. Add 10μ of 3M sodium acetate (PH=4.8) and 350μ of ethanol, let stand at -20℃ for 4 hours, centrifuge at high speed, and dry the resulting DNA pellet.
of distilled water. For this DNA 17μ solution, as shown below:
1μ of pBR322 Hind/alkaline phosphatase treatment (DNA 1μg/μ) and DNA binding enzyme buffer [650mMTrisHCl (PH=
7.4), 65mMMgCl, 10mMDTT, 4mMATP,
Add 2μ of 40mM MSpermide aqueous solution and 0.5μ of T4 DNA ligase (manufactured by Takara Shuzo Co., Ltd. code No. 2010B1.2 units/μ) and react at 14°C for 22 hours.
Next, treat the hybrid DNA at 65℃ for 5 minutes.
get. Next, we used this hybrid DNA to infect E. coli.
Transform HB101 compatible cells. pBR322 BamH/alkaline phosphatase treatment solution; pBR322 Hind/alkaline phosphatase treatment (DNA 1μg/μ) solution plasmid
Add the above to a 340μ aqueous solution containing 50μg of pBR322DNA.
Hind restriction enzyme buffer 40μ and Hind
Add 20μ and react for 10 hours at 37℃, then add 1MTrisHCl (PH
8.0) was added, 10μ of bacterial alkaline phosphatase (BAP) (0.4 units/μ, manufactured by Worthington) was added, and the mixture was treated at 65°C for 7 hours. This reaction dephosphorylates the 5' end of DNA.
This reaction solution was subjected to protein removal using 400μ of water-saturated phenol. Next, protein was further removed twice with 400μ of a phenol/chloroform (4/1 volume ratio) mixture, and finally, the phenol component was extracted from the aqueous solution three times with 600μ of ether. 30μ of 3M sodium acetate and 110μ of ethanol were added to the 350μ of the aqueous layer, allowed to stand at −20°C for 2 hours, and centrifuged at high speed. The resulting DNApellet was dried and dissolved in 50μ of distilled water. This is used as the pBR322 Hind/alkaline phosphatase treatment (DNA 1 μg/μ) solution. Preparation of competent cells of E. coli HB101 and their transformation; A single colony of E. coli HB101 was grown in culture medium L.
The cells were transferred to 5 ml of -broth and cultured with shaking at 37°C for 11 hours. This 2 ml was inoculated into 200 ml of new L-broth, and cultured with shaking at 37°C for 2 hours and 20 minutes. When the OD 600 reached 0.40,
Cool the culture solution to 0°C and use Tommy's refrigerated high-speed centrifuge.
Centrifugation was performed at 5000 rpm for 5 minutes in a No. 9 rotor. Discard the supernatant, homogeneously disperse the precipitated E. coli in 50 ml of 10 mM NaCl water, centrifuge again at high speed (No. 4 rotor, 5000 rpm for 5 minutes) to precipitate the bacteria, and add 60 ml of 30 mM CaCl 2 water to the bacterial pellet to homogenize the whole. The temperature was maintained at 0°C for 20 minutes. High-speed centrifugation again (No. 4 rotor, 4000 rpm for 5 minutes)
Discard the supernatant and add 10ml of 30mMCaCl2 to the bacterial pellet.
Add a 15% aqueous glycerol solution to gently homogenize the whole, dispense 200μ aliquots into 1.5ml Eppendorf tubes, and store frozen at -80°C. this
Escherichia coli HB101 treated with CaCl 2 (referred to as competent cells) was transformed. For transformation, return the competent cells to 0°C, and after about 10 minutes,
Perform the binding reaction with T4 DNA ligase and then 65℃5
The hybrid DNA aqueous solution treated for 1 minute was added, held at 0°C for 40 minutes, and then heated at 42°C for 2 minutes. Next, 1.5 ml of L-broth was added and kept at 37°C for 1 hour, and the culture solution was spread on 8 L-agar plates (diameter 9 cm) containing 50 μ/ml ampicillin at a rate of about 200 μ per plate. Hold at 37℃ for 16 hours
41 transformed HB101 colonies were obtained.
These 41 colonies were plasmidized using the Boiling Lysis method described in the experimental book by Maniathes et al., page 368.
Perform a mini-prep of DNA, then plasmid DNA
Hind disassembled. As a result, 2.58Kbp, 1.62Kbp,
A plasmid containing 1.02Kbp was obtained. 2.58 Kbp was obtained by Hind cleavage of the DNA shown in Figure a, and 1.62 Kbp and 1.02 Kbp were two types of fragments generated by Hind cleavage of the DNA shown in Figure b. 2.58Kbp fragment and
pBGH1, hybrid DNA with pBR322
Hybrid DNA of 1.6NKbp fragment and pBR322
Hybrid of pBGH29 1.02Kbp and pBR322
The DNA was designated as pBGH4. The DNA of pBGH1 is
pBR322 is replicated in host E. coli.
The entire DNA was completely double-stranded. Hybrid DNApBGH1 Hind/Bgl,
Hind/Ava, Hind/Sal/Cla, Hind
/Bgl/Ava, Hind/Cla/Bgl, and then subjected to 1.2% agarose gel electrophoresis (at the same time, EcoR of λDNA was used as a size marker).
The DNA fragment size was analyzed and the results shown in Table 2 were obtained.

【表】 表2の各制限酵素によるpBGH1の分解により
生じた断片は各DNAサイズに±0.05Kbp最大±
0.1Kbp程度の測定誤差が含まれるが、Hindサ
イトから0.82Kbp離れたCla部位がClaにて切
断されなくなつている他は、図aの制限酵素切
断地図から予想されているものによく一致してい
た。 Hindサイトから0.82Kbp離れたCla部位が
Claで切断されなくなつているのは、大腸菌
HB101でpBGH1が複製する際にATCGAT〓
TAGCTAのGATのAの6位Nがメチル化を受
けた為と考えられる。ハイブリツドDNApBGH1
を使つた感染性テスト(実施例i)で感染性を
示すことからpBGH1は見掛け上Claサイトが
一ケ所消失した様に観察されるが、塩基配列その
ものはaDNAと同一と考えられる。 f 二本鎖化DNAのCla分解物と大腸菌プ
ラスミドpBR322のハイブリツドDNA; eの実験に於て二本鎖化DNA及び
pBR322をHind分解するところをCla分解
するのに変えて(分解の際塩濃度はCla分解
用の低濃度に変更)eとほぼ同一の操作を行
い、Cla分解された二本鎖化DNAの滅菌水
17μ及びpBR322のCla/アルカリホスフア
ターゼ処理(DNA1μg/μ)液1μ及び前
記DNA結合酵素用バツフアー2μ及び
T4DNAリガーゼ0.5μを用いて14℃22時間反
応させeの実験と同様にしてハイブリツド
DNAを得た。このハイブリツドDNAを用い
て、eと同様の操作により大腸菌HB101コ
ンピテントセルの形質転換を行い41ケの形質転
換体を得た。この41ケのコロニーをeの場合
と同様Boiling Lysis法によりプラスミドDNA
のミニ調製を行い、このプラスミドDNAを
Cla分解した。その結果2.61Kbp、1.33Kbp、
1.24Kbpの断片を含む3種のハイブリツドプラ
スミドを得た。このハイブリツドプラスミド
DNAをpBGC1、pBGC2、pBGC3とした。
pBGC1はbのDNA全体を含有するハイブリ
ツドDNAであり、pBGC2及びpBGC3は
bDNAの2つのCla断片を含有するハイブリ
ツドDNAであつた。ハイブリツド
DNApBGC1は大腸菌の内で複製増殖したもの
でDNA全体に亘つて完全に二本鎖化していた。
ハイブリツドDNApBGC1をC1a、Cla/
Hind、Cla/Salで分解し、eと同様
に分野断片を解析した。得られた断片のサイズ
は表3の様になつた。
[Table] The fragments generated by digestion of pBGH1 with each restriction enzyme in Table 2 have a maximum of ±0.05Kbp for each DNA size.
Although there is a measurement error of about 0.1 Kbp, the result matches well with what was expected from the restriction enzyme cleavage map in Figure a, except that the Cla site 0.82 Kbp away from the Hind site is no longer cleaved by Cla. was. The Cla site 0.82Kbp away from the Hind site is
E. coli is no longer cleaved by Cla.
ATCGAT when pBGH1 replicates in HB101
This is thought to be due to methylation at position 6 N of GAT in TAGCTA. Hybrid DNApBGH1
Since pBGH1 was found to be infectious in an infectivity test using (Example i), it appears that one Cla site has disappeared, but the base sequence itself is thought to be the same as aDNA. f Hybrid DNA of Cla-digested double-stranded DNA and E. coli plasmid pBR322; In the experiment of e, double-stranded DNA and
Sterilize the double-stranded DNA that has been digested with Cla by performing almost the same procedure as e, changing the Hind digestion of pBR322 to Cla digestion (change the salt concentration during digestion to a low concentration for Cla digestion). water
17μ and pBR322 Cla/alkaline phosphatase treatment (DNA 1μg/μ) solution 1μ and the buffer for DNA binding enzyme 2μ and
Hybrids were incubated using 0.5μ of T4 DNA ligase at 14℃ for 22 hours in the same manner as in experiment e.
I got DNA. Using this hybrid DNA, E. coli HB101 competent cells were transformed in the same manner as in e. 41 transformants were obtained. Plasmid DNA was extracted from these 41 colonies using the Boiling Lysis method as in the case of e.
Make a mini preparation of this plasmid DNA
Cla decomposed. The results were 2.61Kbp, 1.33Kbp,
Three hybrid plasmids containing a 1.24 Kbp fragment were obtained. This hybrid plasmid
The DNAs were named pBGC1, pBGC2, and pBGC3.
pBGC1 is a hybrid DNA containing the entire DNA of b, pBGC2 and pBGC3 are
It was a hybrid DNA containing two Cla fragments of bDNA. hybrid
DNApBGC1 was replicated in E. coli and was completely double-stranded throughout the DNA.
Hybrid DNApBGC1 was transferred to C1a, Cla/
It was decomposed using Hind and Cla/Sal, and the field fragments were analyzed in the same manner as e. The sizes of the obtained fragments were as shown in Table 3.

【表】 表3の各制限酵素によるpBGC1の分解によ
り生じた断片は、各DNAのサイズに±0.05最
大±0.1Kbp程度の測定誤差が含まれるが、図
bの制限酵素切断地図に示されるものによく
一致していた。 本実施例e及びfで得られるハイブリツ
ドDNApBGH1及びpBGC1は夫々図a及び
bのDNAとpBR322とのハイブリツドDNA
であり、これらも植物組み換え用ベクターにな
り得る。 g ハイブリツドDNApBGH1及びpBGC1か
らaDNA及びbDNAの分離及びその結合
環化; ハイブリツドDNApBGH1及びpBGC1夫々
20μgを夫々Hind20ユニツト、Cla20ユニ
ツト使用し夫々の前記制限酵素用バツフアーに
より塩濃度を設定し、total 400μにて37℃10
時間加水分解した。次に0.8%アガロースゲル
(スロツト幅1.5mm、長さ6cm、深さ7mm、ゲル
長13cm)を使用し1V/cmで10時間電気泳動後、
aDNA、bDNAバンド部分をゲルごと切
り取り前記マニアテイスらの実験書P164〜5
記載の方法でDNAをゲルより抽出し、次に
P166の方法に従つてDNAを精製した。ともに
滅菌水50μ(DNA約0.1μg/μ)に溶解し
た。この線状のaDNA及びbDNAをこの
線状aDNA及びbDNAの夫々20μに夫々
前記DNA連結酵素用バツフアー5μ、滅菌水
25μ、T4−DNAリガーゼ0.5μを加え12℃
19時間反応させた後、再び上と同様に0.8%ア
ガロースゲル電気泳動を行い、見掛け上の大き
さ3.3KbpのDNAバンド部分をゲルごと切り出
し前述と同様の方法でDNAのみを抽出精製し
た。このDNAは夫々環状のaDNA及び
bDNAになつていると考えられる。次にこの
DNA夫々に滅菌水10μを加え、その2μに
対し、夫々Hind、Claによる部分分解を行
つた。部分分解は、DNAの2μ溶液に前記制
限酵素用バツフアーを5μ、滅菌水43μ加
え、更にaDNAの方にはHindを0.5ユニツ
ト、bDNAの方にはCla0.5ユニツトを加
え、37℃で5分、10分、30分反応させ夫々の反
応物を0.8%アガロースゲル電気泳動を行いサ
イズの変化を見た。5分、10分、30分と反応さ
せるに従い3.3Kbpのバンドが徐々に減少し
aDNA及びbDNAの線状DNA2.57Kbp、
2.61Kbp、のバンドが増加し、それ以外のバン
ドは認められなかつた。このことから上の環状
のaDNA、bDNAはともに一量体で環状
となつたものであり夫々図a,bのDNA
である。このDNAはDNAの全体に亘つて完全
に二本鎖化されていて、植物組み換え用ベクタ
ーとして利用出来る。 h BGMV感染植物からBGMV複製型DNA
の抽出、分析; ハミルトンらの方法〔Nucl Acids Res.10
4902(1982)記載〕に従い、トツプクロツプイ
ンゲンのBGMV感染葉21gに40mlの
0.5MKH2PO4、0.75%Na2SO5(PH7.0)を加え
乳鉢にて均一化し、TritonX−100 1.2mlを加
え4℃で25時間撹拌した。次に二重ガーゼにて
過し、過部分をトミー高速遠心機にてNo.4
ローターを用い9000rpm10分間遠心し、上清を
取りこの上清をベツクマン超遠心機タイプ
SW40.1ローターにて37000rpm3.5時間遠心し
た。上清は捨て沈殿物ペレツトに1mlの
40mMTrisHCl、5mM酢酸、10mMEDTA(PH
8.2)を加え均一化し20μの10%SDSを加え更
に1mlの水飽和フエノールで3回、次に1mlの
フエノール/クロロホルム(4/1)で3回水
層からタンパク質等を除いた。次にエーテル1
mlにて4回エーテル抽出を行いフエノールを除
き、水層に3P酢酸ナトリウム100μ及びエタ
ノール3.5mlを加え−20℃一昼夜放置後、高速
遠心しDNAペレツトを得た。このDNAペレツ
トに500μの滅菌水を加え(DNA濃度0.6μ
g/μ)その100μを前記1gと同様の手
法により0.8%アガロースゲル電気泳動を行い、
BGMVの32pラベルDNAプローブとハイブリ
ダイズするバンド1.5Kbp相当部分のDNA、
3.1Kbp相当部分のDNA、5.2Kbp相当部分の
DNA、9.8Kbp部分のDNAをgと同様の手
法でゲルからDNAを取り出し精製した。
(5.2Kbp相当部分、9.8Kbp相当部分はλ−
DNAのEcoR/Hindのサイズマーカーを
使用し、夫々の相当部分のゲルを切り出した)。 この4種のDNAを夫々Hind、Cla、Sal
で分解しアガロースゲル電気泳動を行い、そ
の分解パターンを解析した。5.2Kbp相当部分、
9.8Kbp相当部分のDNAについてはアガロース
ゲル電気泳動後のDNAをニトロセルロースフ
イルターに移動させ、32pラベルしたBGMVの
DNAを用いてDNA−DNAハイブリダゼーシ
ヨン及びオートラジオグラフイーを行いDNA
の分解パターンを解析した。その分解パターン
はHind分解によつて2.58、1.60、1.00Kbp、
Cla分解によつて2.57、1.33、1.24Kbp、Sal
分解によつて1.90、1.54、1.03、0.71Kbpの分
解パターンを示した。これはa、bの夫々
の制限酵素による分解パターンと同じであり、
即ち本複製型DNAはDNA−a又はDNA−
bを含有しており植物組み換え用ベクターと
して利用出来る。 i 複製型DNAとpBR322とのハイブリツド
DNAの作製; hの複製型DNAのうち見掛け上1.5Kbp相
当サイズのバンド部分のアガロースゲルより抽
出精製したDNA(9μgDNA/10μ)に、前
記Cla制限酵素用バツフアー4μ、滅菌水
24μ、Cla3μ加え、37℃で2時間加水分
解し、これに滅菌水60μを加え、水飽和フエ
ノール60μで2回除タンパク処理し、次いで
エーテル130μで4回、水層よりフエノール
抽出を行つた。次に7μの3M酢酸ナトリウム
(PH4.8)、更にエタノール300μを加え−80℃
で30分間放置後、高速遠心し沈殿物を得た。冷
70%エタノール500μでこの沈殿物を洗い再
び遠心し上清は捨て沈殿物を2mmHg、3分間
乾燥した。この沈殿を20μの滅菌水に溶解
し、これを複製型DNAのCla分解物とする。
このCla分解物4μ(DNA約2μg)にf
で使用したと同じpBR322のCla分解/アル
カリホスフアターゼ処理液(DNA1μg/μ
)6μ、前記DNA結合酵素用バツフアー2μ
及びT4DNAリガーゼ0.5μ、滅菌水7.5μ
加えて14℃12時間反応させ次に65℃5分間処理
して、fと同様の操作により大腸菌HB101
のコンピテントセルの形質転換を行い約500ケ
の形質転換体を得た。 形質転換体のコロニーの生じているL−
Agarプレートの上にニトロセルロースフイル
ター(Schleicher und Schiill社製BA85:前
記も同じ)を乗せ、次にニトロセルロースフイ
ルターを取り、このフイルターを0.5M水酸化
ナトリウム、1.5M食塩水に1分間浸たし、次
に1M TrsHCl(PH7.0)液に浸した。このニト
ロセルロースフイルターを80℃で2時間、1mm
Hgに減圧し熱処理した。この熱処理フイルタ
ーをプレハイブリダイゼーシヨン溶液〔0.9M
NaCl、0.09Mクエン酸ナトリウム、0.02%ポリ
ビニルピロリドン(和光純薬(株)プラスドンNP
K−30)0.02%フアイコール(フアルマシアフ
アインケミカルス社製Ficoll400)0.02%牛血清
アルブミンの水溶液〕に浸し、63℃30分間前処
理し、次いでプレハイブリダイゼーシヨン溶液
を除き新たにプレハイブリダイゼーシヨン溶液
にSDSが10%及び酵母tRNA40μg/mlとなる
ように加えたハイブリダイゼーシヨン溶液及び
下記のBGMVの32pプローブ200×104cpmを加
えこの液の中に前記の処理をしたニトロセルロ
ースフイルターを入れ63℃24時間DNA−DNA
ハイブリダイゼーシヨンを行つた。次にこのフ
イルターを取り出し、多量の0.45M NaCl、
0.045Mクエン酸ナトリウムの中で55℃20分間
ゆつくり振盪しフイルターを洗浄した。この洗
浄を3回行い、乾燥させ次いでこのフイルター
を使つて前記マニアテイスらの実験書P470〜
471と同様の手法でオートラジオグラフイーを
行つた。32pラベルしたBGMVのDNAとハイ
ブリダイズするコロニーは約360ケ認められた。 BGMVの32pプローブの調製; cの実験にで、0.8mMデオキシシチジン三
リン酸を10μの代に0μとする。他はcと同
様にしてセフアデツクスG−75のゲル過にてNo.
6〜11の階画分に最初の32pのピーク(total800
×104cpm)があり、これらの画分を集め
(tctal900μ)、95℃5分加勢し、次いで0℃に
急冷した。この液を32pラベルしたBGMVの
DNAプローブとする。前記360ケのコロニーのう
ち30ケのコロニーにつき前述のBoiling Lysis法
によりプラスミドDNAのミニ調製を行いプラス
ミドDNAをCla分解した。その結果7ケのコ
ロニーから2.61Kbpの断片を含むハイブリツドプ
ラスミドを得た。このハイブリツドDNAの一つ
をpBGRFC1とした。pBGRFC1をCla/Hind
、Cla、Solで分解したらfの表3と同
一のDNA断片を示した。 j 複製型DNAとpBR322とのハイブリツド
DNAの作製; hの複製型DNAのうち見掛けと3.1Kbp相
当サイズのバンド部分から抽出精製したDNA
をHinpで分解し、これをeと同様に
pBR322のHind/アルカリホースフアターゼ
処理液とでハイブリツドDNAを得、更に大腸
菌を形質転換してeと同様に得られた形質転
換体161ケのうち30ケからプラスミドを抽出解
析してeと同様にpBR322のHind部位に部
位に2.58Kbp、1.59Kbp、0.99KbpのHind断
片を含むハイブリツドDNA夫々pBGRFH1、
pBGRFH2、pBGRFH3を得た。 pBGRFH1はHind/Bgl、Hind/
Ava、Hind/Cla/Salの分解でe
の表2の場合と同様のDNA断片を生じた。
i及びjの結果から本複製型DNAは図
aDNA及びbDNAを含んでいることが認め
られた。本実験の手法を用いればaDNA、
bDNAのそれぞれを分離することも出来ま
た増殖することも可能である。 k クローニングDNAによる感染性; eで得たハイブリツドDNApBGH1(2.3μ
g/μ)25μに2mMMgCl210μ、前記
Hind制限酵素用バツフアー13μ、Hind
5μ、滅菌水77μを加え37℃7時間処理し、
更に65℃5分間処理後NaCl及びクエン酸ナト
リウムを夫々0.15M、0.015Mとなるまで添加
した。この液をクローニングaDNA液とし
た。fで得たハイブリツドDNA pBGC6
(0.68μg/μ)100μに2mMMgCl210μ、
前記Cla制限酵素用バツフアー13μ、Cla
5μ、滅菌水2μを加え、37℃7時間処理し、
更に65℃5分間処理後、NaCl及びクエン酸ナ
トリウムを夫々0.15M、0.015Mとなるまで添
加した。この液をクローニングbDNA液と
した。クローニングaDNA液及び、
bDNA液の夫々80μを混合しこの混合液を昼
間状態で14時間30℃、夜間状態で10時間27℃、
湿度80%以上に設定したバイオトロン(小糸製
作所製コイトトロン)中で、発芽後6日目のト
ツプクロツプインゲンの若葉の表面に、セライ
トとともに滅菌手袋を使用しこすりつけ接種し
た(混合液40μ/1個体トツプクロツプイン
ゲン)。全部で4個体に接種した。バイオトロ
ン内の条件はその後も前記同様に維持してトツ
プクロツプインゲン本葉にビーンゴールデンモ
ザイク病の発病を観察した。接種後10日目にビ
ーンゴールデンモザイク病が4個体ともに顕著
に認められた。 以上のことからクローニングaDNA及び
bDNAはクローニングにより特別の塩基配
列の所が、例えばGATCのAの6位のNがメ
チル化などされて図a,bの制限酵素切断
地図の特定の制限部位(例えばCla部位の1
つ)が消失し異なつたDNAの様に見掛け上観
察されても塩基配列そのものは同一であり、
DNAとして同一の感染性を示す故にウイルス
のDNAと同一の塩基配列のものであると認め
られる。 k クローニングDNAによる感染性; eで得たハイブリツドDNApMYB4
(0.435μg/μ)460μに2mMMgCl210μ、
前記BamH制限酵素用バツフアー55μ、
BamH10μ、滅菌水15μを加え37℃4時
間酵素処理し、更に65℃5分間処理後
1.5MNaCl及び0.15Mクエン酸ナトリウム水溶
液を55μ添加した。この液をクローニング
aDNA液とした。fで得たハイブリツド
DNApMYH3(0.87μg/μ)231μに
2mMMgCl210μ、前記Hind制限酵素用バ
ツフアー30μ、Hind10μ、滅菌水19μを
加え、37℃4時間酵素処理し、更に65℃5分間
処理後、1.5MNaCl及び0.15Mクエン酸ナトリ
ウム水溶液を30μ添加した。この液をクロー
ニングbDNA液とした。 クローニングaDNA液330μ及び
bDNA液を160μを混合し、この混合液を、
昼間状態で14時間30℃、夜間状態で10時間27
℃、湿度80%以上に設定したバイオトロン(小
糸製作所製コイトトロン)中で、発芽後6日目
のトツプクロツプインゲンの若葉表面に、セラ
イトとともに滅菌手袋を使用し、こすりつけ接
種した(混合液46μ/1個体トツプクロツプ
インゲン)。全部で10個体に接種した。バイオ
トロン内の条件は、その後も前記同様に維持し
てトツプクロツプインゲン本葉にイエローモザ
イク病斑の発現を観察した。接種後18日目にイ
エローモザイク病斑が10個体中9個体に顕著に
認められた。 以上のことから本発明で得られたクローニン
グaDNA及びbDNAは、クローニングに
より特別の塩基配列、例えばGATCのAの6
位のNがメチル化等されていても、ウイルスの
DNAと同じ感染性を示す。このことから実質
的に同一の塩基配列のものと考え得る。
[Table] The fragments generated by digestion of pBGC1 with each restriction enzyme in Table 3 include a measurement error of ±0.05 maximum ±0.1 Kbp in the size of each DNA, but the fragments shown in the restriction enzyme cleavage map in Figure b was in good agreement. The hybrid DNAs pBGH1 and pBGC1 obtained in Examples e and f are hybrid DNAs of the DNA shown in Figures a and b and pBR322, respectively.
These can also be used as vectors for plant recombination. g Separation of aDNA and bDNA from hybrid DNA pBGH1 and pBGC1 and their combined circularization; hybrid DNA pBGH1 and pBGC1 respectively
Using 20 µg of Hind20 units and 20 Cla units, set the salt concentration using the respective restriction enzyme buffers, and incubate at 37℃10 at a total of 400 µg.
Hydrolyzed for hours. Next, after electrophoresis using 0.8% agarose gel (slot width 1.5 mm, length 6 cm, depth 7 mm, gel length 13 cm) at 1 V/cm for 10 hours,
The aDNA and bDNA band parts were cut out along with the gel and the experimental book by Maniathes et al. P164-5
DNA was extracted from the gel as described, and then
DNA was purified according to the method of P166. Both were dissolved in 50μ of sterile water (approximately 0.1μg/μ of DNA). Add this linear aDNA and bDNA to 20μ each of the linear aDNA and bDNA with 5μ of the buffer for DNA ligation enzyme and sterilized water.
Add 25μ, T4-DNA ligase 0.5μ and 12℃
After reacting for 19 hours, 0.8% agarose gel electrophoresis was performed again in the same manner as above, and the DNA band with an apparent size of 3.3 Kbp was cut out from the gel, and only the DNA was extracted and purified in the same manner as described above. This DNA is circular aDNA and
It is thought that it has become bDNA. Then this
10μ of sterile water was added to each DNA, and 2μ of the water was partially degraded with Hind and Cla, respectively. For partial digestion, add 5μ of the above restriction enzyme buffer and 43μ of sterile water to a 2μ solution of DNA, then add 0.5 unit of Hind for aDNA and 0.5 unit of Cla for bDNA, and incubate at 37°C for 5 minutes. After reacting for 10 minutes and 30 minutes, each reaction product was subjected to 0.8% agarose gel electrophoresis to observe changes in size. The 3.3Kbp band gradually decreased as the reaction was carried out for 5, 10, and 30 minutes.
aDNA and bDNA linear DNA 2.57Kbp,
A band of 2.61 Kbp increased, and no other bands were observed. From this, the above circular aDNA and bDNA are both monomeric and circular, and are the DNAs in Figures a and b, respectively.
It is. This DNA is completely double-stranded throughout and can be used as a vector for plant recombination. h BGMV replicative DNA from BGMV infected plants
extraction and analysis; method of Hamilton et al. [Nucl Acids Res. 10
4902 (1982)], 40ml of
0.5MKH 2 PO 4 and 0.75% Na 2 SO 5 (PH7.0) were added and homogenized in a mortar, 1.2 ml of TritonX-100 was added, and the mixture was stirred at 4°C for 25 hours. Next, pass through double gauze, and transfer the excess portion to a No. 4 Tommy high-speed centrifuge.
Centrifuge at 9,000 rpm for 10 minutes using a rotor, remove the supernatant, and transfer this supernatant to a Betsuman ultracentrifuge type.
Centrifugation was performed at 37,000 rpm for 3.5 hours in an SW40.1 rotor. Discard the supernatant and add 1 ml to the sediment pellet.
40mM TrisHCl, 5mM acetic acid, 10mM MEDTA (PH
8.2) was added and homogenized, 20μ of 10% SDS was added, and proteins etc. were removed from the aqueous layer three times with 1 ml of water-saturated phenol and then three times with 1 ml of phenol/chloroform (4/1). Next, ether 1
Ether extraction was carried out four times to remove phenol, and to the aqueous layer were added 3P sodium acetate (100μ) and ethanol (3.5ml), and after standing at -20°C overnight, the mixture was centrifuged at high speed to obtain a DNA pellet. Add 500μ of sterile water to this DNA pellet (DNA concentration: 0.6μ).
g/μ) The 100μ was subjected to 0.8% agarose gel electrophoresis using the same method as for 1g.
DNA corresponding to 1.5 Kbp of the band that hybridizes with the 32p labeled DNA probe of BGMV,
DNA equivalent to 3.1Kbp, DNA equivalent to 5.2Kbp
The 9.8 Kbp portion of DNA was extracted from the gel and purified in the same manner as in g.
(The portion equivalent to 5.2Kbp and the portion equivalent to 9.8Kbp are λ−
Using DNA EcoR/Hind size markers, a corresponding portion of each gel was cut out). These four types of DNA are respectively Hind, Cla, and Sal.
The decomposition pattern was analyzed by performing agarose gel electrophoresis. 5.2Kbp equivalent portion,
For the DNA corresponding to 9.8 Kbp, the DNA after agarose gel electrophoresis was transferred to a nitrocellulose filter, and the 32p-labeled BGMV was transferred to a nitrocellulose filter.
Perform DNA-DNA hybridization and autoradiography using DNA.
The decomposition pattern of was analyzed. The decomposition pattern is 2.58, 1.60, 1.00Kbp,
2.57, 1.33, 1.24Kbp, Sal by Cla decomposition
Degradation patterns showed degradation patterns of 1.90, 1.54, 1.03, and 0.71 Kbp. This is the same pattern of digestion by restriction enzymes a and b,
That is, this replicative DNA is DNA-a or DNA-
b, and can be used as a vector for plant recombination. i Hybrid of replicative DNA and pBR322
Preparation of DNA: DNA (9 μg DNA/10 μ) extracted and purified from agarose gel of a band portion with an apparent size of 1.5 Kbp among the replicated DNA of h, was added with 4 μ of the Cla restriction enzyme buffer and sterile water.
24μ of Cla and 3μ of Cla were added and hydrolyzed at 37°C for 2 hours, 60μ of sterilized water was added thereto, protein was removed twice with 60μ of water-saturated phenol, and then phenol was extracted from the aqueous layer four times with 130μ of ether. Next, add 7μ of 3M sodium acetate (PH4.8) and 300μ of ethanol at −80℃.
After standing for 30 minutes, the mixture was centrifuged at high speed to obtain a precipitate. cold
The precipitate was washed with 500μ of 70% ethanol, centrifuged again, and the supernatant was discarded, and the precipitate was dried at 2 mmHg for 3 minutes. This precipitate is dissolved in 20μ of sterile water, and this is used as a Cla degradation product of replicative DNA.
Add f to 4μ of this Cla decomposition product (approx. 2μg of DNA).
The same pBR322 Cla digestion/alkaline phosphatase treatment solution used in
) 6μ, buffer for the DNA-binding enzyme 2μ
and T4 DNA ligase 0.5μ, sterile water 7.5μ
In addition, the reaction was carried out at 14℃ for 12 hours, and then treated at 65℃ for 5 minutes.
Competent cells were transformed and approximately 500 transformants were obtained. L- in which colonies of transformants have arisen
Place a nitrocellulose filter (BA85 manufactured by Schleicher and Schiill; same as above) on the Agar plate, then remove the nitrocellulose filter and soak it in 0.5M sodium hydroxide and 1.5M saline for 1 minute. , and then immersed in 1M TrsHCl (PH7.0) solution. This nitrocellulose filter was heated to 80°C for 2 hours to 1mm
The pressure was reduced to Hg and heat treated. Add this heat-treated filter to prehybridization solution [0.9M]
NaCl, 0.09M sodium citrate, 0.02% polyvinylpyrrolidone (Wako Pure Chemical Industries, Ltd. Plasdone NP)
K-30) 0.02% Ficoll (Ficoll 400, manufactured by Pharmacia Fine Chemicals) 0.02% bovine serum albumin aqueous solution], pretreated at 63°C for 30 minutes, then removed the prehybridization solution and pre-hybridized anew. A hybridization solution containing 10% SDS and 40 μg/ml of yeast tRNA was added to the dissolution solution, and 200 x 10 4 cpm of the BGMV 32p probe described below was added to the solution. Add cellulose filter and DNA-DNA at 63℃ for 24 hours.
Hybridization was performed. Next, take out this filter, add a large amount of 0.45M NaCl,
The filter was washed by gentle shaking in 0.045M sodium citrate at 55°C for 20 minutes. This washing was carried out three times, and then after drying, using this filter,
Autoradiography was performed using the same method as 471. Approximately 360 colonies were observed that hybridized with 32p-labeled BGMV DNA. Preparation of BGMV 32p probe: In experiment c, 0.8mM deoxycytidine triphosphate was used instead of 10μ to 0μ. Other procedures were carried out in the same manner as in c, and No.
The first 32p peak in the 6th to 11th floor fractions (total 800
These fractions were collected (tctal 900μ), heated at 95°C for 5 minutes, and then rapidly cooled to 0 °C. This liquid is 32p labeled BGMV.
Use as a DNA probe. Plasmid DNA was mini-prepared from 30 of the 360 colonies by the Boiling Lysis method described above, and the plasmid DNA was digested with Cla. As a result, a hybrid plasmid containing a 2.61 Kbp fragment was obtained from 7 colonies. One of these hybrid DNAs was named pBGRFC1. Cla/Hind pBGRFC1
, Cla, and Sol showed the same DNA fragment as in Table 3 of f. j Hybrid of replicative DNA and pBR322
Preparation of DNA; DNA extracted and purified from the band portion of the replicative DNA of h with a size equivalent to the apparent size of 3.1 Kbp.
is decomposed by Hinp, and this is done similarly to e.
Hybrid DNA was obtained with pBR322 treated with Hind/alkaline horsphatase, and E. coli was further transformed. Plasmids were extracted and analyzed from 30 of the 161 transformants obtained in the same manner as e. Hybrid DNA containing Hind fragments of 2.58Kbp, 1.59Kbp, and 0.99Kbp at the Hind site of pBR322, respectively pBGRFH1,
pBGRFH2 and pBGRFH3 were obtained. pBGRFH1 is Hind/Bgl, Hind/
Ava, Hind/Cla/Sal decomposition e
DNA fragments similar to those in Table 2 were generated.
From the results of i and j, this replicative DNA is shown in the figure.
It was confirmed that it contained aDNA and bDNA. Using the method of this experiment, aDNA,
Each bDNA can be isolated and propagated. k Infectivity by cloned DNA; hybrid DNA pBGH1 (2.3μ) obtained in e.
g/μ) 25μ to 2mMMgCl 2 10μ, above
Hind restriction enzyme buffer 13μ, Hind
Add 5μ and 77μ of sterile water and treat at 37℃ for 7 hours.
After further treatment at 65°C for 5 minutes, NaCl and sodium citrate were added until the concentrations were 0.15M and 0.015M, respectively. This solution was used as a cloning aDNA solution. Hybrid DNA pBGC6 obtained in f.
(0.68μg/μ) 10μ of 2mMMgCl2 in 100μ,
Buffer 13μ for Cla restriction enzyme, Cla
Add 5μ of sterilized water and 2μ of sterilized water and treat at 37℃ for 7 hours.
After further treatment at 65°C for 5 minutes, NaCl and sodium citrate were added until the concentrations were 0.15M and 0.015M, respectively. This solution was used as a cloning bDNA solution. Cloning aDNA solution and
Mix 80μ of each bDNA solution and store the mixture at 30°C for 14 hours during the day and at 27°C for 10 hours at night.
In a Biotron (Koitotron manufactured by Koito Manufacturing Co., Ltd.) set at a humidity of 80% or higher, the surfaces of young leaves of Topkurotsupin bean, 6 days after germination, were inoculated by rubbing together with Celite using sterile gloves (mixed solution 40μ/1 Individual top crop beans). A total of 4 individuals were inoculated. Thereafter, the conditions in the biotron were maintained as described above, and the onset of bean golden mosaic disease was observed on the true leaves of top-cropped kidney beans. Ten days after inoculation, bean golden mosaic disease was clearly observed in all four individuals. From the above, cloning aDNA and
When bDNA is cloned, a special base sequence is methylated, for example N at position 6 of A of GATC, and specific restriction sites (for example, Cla site 1 of the restriction enzyme cleavage map in Figures a and b) are
Even though it appears that the DNA has disappeared and is different, the base sequence itself is the same.
Since it exhibits the same infectivity as DNA, it is recognized to have the same base sequence as viral DNA. k Infectivity by cloned DNA; hybrid DNA pMYB4 obtained in e.
(0.435μg/μ) 2mMgCl 2 10μ to 460μ,
55μ buffer for the BamH restriction enzyme,
After adding 10μ of BamH and 15μ of sterile water and enzymatic treatment at 37℃ for 4 hours, further treatment at 65℃ for 5 minutes.
55μ of 1.5M NaCl and 0.15M sodium citrate aqueous solution was added. Cloning this liquid
It was made into aDNA solution. Hybrid obtained by f
DNApMYH3 (0.87μg/μ) to 231μ
10μ of 2mMMgCl 2 , 30μ of the Hind restriction enzyme buffer, 10μ of Hind, and 19μ of sterilized water were added, and the mixture was treated with enzymes at 37°C for 4 hours. After further treatment at 65°C for 5 minutes, 30μ of 1.5M NaCl and 0.15M sodium citrate aqueous solution were added. This solution was used as a cloning bDNA solution. Cloning aDNA solution 330μ and
Mix 160μ of bDNA solution, and add this mixture to
30℃ for 14 hours in daytime condition, 10 hours in nighttime condition 27
In a Biotron (Koitoron manufactured by Koito Seisakusho Co., Ltd.) set at ℃ and humidity of 80% or higher, inoculation was inoculated by rubbing it with Celite on the surface of young leaves of Topkurotsupin bean on the 6th day after germination using sterile gloves. / 1 individual top cropped green bean). A total of 10 individuals were inoculated. Thereafter, the conditions in the biotron were maintained in the same manner as described above, and the appearance of yellow mosaic lesions was observed on the true leaves of the top crop kidney bean. On the 18th day after inoculation, yellow mosaic lesions were clearly observed in 9 out of 10 individuals. From the above, the cloned aDNA and bDNA obtained in the present invention have a special base sequence, for example, A6 of GATC, by cloning.
Even if the N at position is methylated, etc., the virus
Shows the same infectivity as DNA. From this, it can be considered that they have substantially the same base sequence.

【図面の簡単な説明】[Brief explanation of drawings]

図a及びbはそれぞれ本発明によるDNA
の制限酵素切断地図を示すものである。
Figures a and b are DNA according to the present invention, respectively.
This shows a restriction enzyme cleavage map of .

Claims (1)

【特許請求の範囲】 1 ビーンゴールデンモザイクウイルスの一本鎖
DNAが少くとも部分的に二本鎖化されたDNAで
あり、下記の遺伝子地図で表わされるDNAの1
〜3量体DNA。 〔ここでP1〜P7における塩基配列は、二本鎖の
うち一方の鎖の塩基配列が下記のとおりである。 P1(0.0/2.57):5′−AAGCTT−3′ P2(0.82) :5′−ATCGAT−3′ P3(0.97) :5′−AGATCT−3′ P4(1.18) :5′−GTCGAC−3′ P5(1.38) :5′−CPyCGPuG−3′ P6(2.08) :5′−ATCGAT−3′ P7(2.21) :5′−GTCGAC−3′〕 2 他の生物中においてその少くとも一部がメチ
ル化されたことを特徴とする特許請求の範囲第1
項記載のDNA。 3 他の生物が大腸菌である特許請求の範囲第2
項記載のDNA。 4 in vitroで二本鎖化された特許請求の範囲第
1項記載のDNA。 5 in vivoで二本鎖化された特許請求の範囲第
1項記載のDNA。 6 1量体であることを特徴とする特許請求の範
囲第1項記載のDNA。 7 ビーンゴールデンモザイクウイルスの一本鎖
DNAが少くとも部分的に二本鎖化されたDNAで
あり、下記の遺伝子地図で表わされるDNAを含
むハイブリツドDNA。 〔ここでP1〜P7における塩基配列は、二本鎖の
うち一方の鎖の塩基配列が下記のとおりである。 P1(0.0/2.57):5′−AAGCTT−3′ P2(0.82) :5′−ATCGAT−3′ P3(0.97) :5′−AGATCT−3′ P4(1.18) :5′−GTCGAC−3′ P5(1.38) :5′−CPyCGPuG−3′ P6(2.08) :5′−ATCGAT−3′ P7(2.21) :5′−GTCGAC−3′〕 8 他の生物中において、その少くとも一部がメ
チル化されたことを特徴とする特許請求の範囲第
7項記載のハイブリツドDNA。 9 他の生物が大腸菌である特許請求の範囲第8
項記載のハイブリツドDNA。 10 in vitroで二本鎖化された特許請求の範囲
第7項記載のハイブリツドDNA。
[Claims] 1. Single strand of bean golden mosaic virus
The DNA is at least partially double-stranded, and is one of the DNAs represented in the genetic map below.
~Trimeric DNA. [Here, the base sequence of one strand of the double strands of P 1 to P 7 is as follows. P 1 (0.0/2.57): 5′−AAGCTT−3′ P 2 (0.82): 5′−ATCGAT−3′ P 3 (0.97): 5′−AGATCT−3′ P 4 (1.18): 5′− GTCGAC−3′ P 5 (1.38) :5′−CPyCGPuG−3′ P 6 (2.08) :5′−ATCGAT−3′ P 7 (2.21) :5′−GTCGAC−3′] 2 In other organisms Claim 1 characterized in that at least a part of it is methylated.
DNA described in section. 3 Claim 2 in which the other organism is E. coli
DNA described in section. 4. The DNA according to claim 1, which has been double-stranded in vitro. 5. The DNA according to claim 1, which has been double-stranded in vivo. 6. The DNA according to claim 1, which is a monomer. 7 Bean golden mosaic virus single strand
Hybrid DNA is DNA that is at least partially double-stranded and includes DNA represented by the genetic map below. [Here, the base sequence of one strand of the double strands of P 1 to P 7 is as follows. P 1 (0.0/2.57): 5′−AAGCTT−3′ P 2 (0.82): 5′−ATCGAT−3′ P 3 (0.97): 5′−AGATCT−3′ P 4 (1.18): 5′− GTCGAC−3′ P 5 (1.38) :5′−CPyCGPuG−3′ P 6 (2.08) :5′−ATCGAT−3′ P 7 (2.21) :5′−GTCGAC−3′] 8 In other organisms 8. The hybrid DNA according to claim 7, wherein at least a portion of the hybrid DNA is methylated. 9 Claim 8 in which the other organism is E. coli
Hybrid DNA as described in Section. 10. The hybrid DNA according to claim 7, which has been double-stranded in vitro.
JP58161946A 1983-09-05 1983-09-05 Novel dna and hybrid dna Granted JPS6054684A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP58161946A JPS6054684A (en) 1983-09-05 1983-09-05 Novel dna and hybrid dna
US06/643,036 US4855237A (en) 1983-09-05 1984-08-21 Double-stranded DNA having sequences complementary to a single-stranded DNA and derived from a bean golden mosaic virus
DE8484110116T DE3484039D1 (en) 1983-09-05 1984-08-24 DOUBLE STRING DNS.
EP84110116A EP0136521B1 (en) 1983-09-05 1984-08-24 Novel, double-stranded dna

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58161946A JPS6054684A (en) 1983-09-05 1983-09-05 Novel dna and hybrid dna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP1502290A Division JPH0367592A (en) 1990-01-26 1990-01-26 New dna and hybrid dna

Publications (2)

Publication Number Publication Date
JPS6054684A JPS6054684A (en) 1985-03-29
JPH0258916B2 true JPH0258916B2 (en) 1990-12-11

Family

ID=15745046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58161946A Granted JPS6054684A (en) 1983-09-05 1983-09-05 Novel dna and hybrid dna

Country Status (4)

Country Link
US (1) US4855237A (en)
EP (1) EP0136521B1 (en)
JP (1) JPS6054684A (en)
DE (1) DE3484039D1 (en)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61132188A (en) * 1984-12-03 1986-06-19 Teijin Ltd Novel dna and hybrid dna
JPS61257186A (en) * 1985-05-10 1986-11-14 Teijin Ltd Novel dna and hybrid dna
JPS63126486A (en) * 1986-11-17 1988-05-30 Teijin Ltd Hybrid dna tandem containing dna fragment of gemini virus
US20030150019A1 (en) * 1988-02-26 2003-08-07 Large Scale Biology Corporation Monopartite RNA virus transformation vectors
US5316931A (en) * 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
US6054566A (en) * 1988-02-26 2000-04-25 Biosource Technologies, Inc. Recombinant animal viral nucleic acids
US6284492B1 (en) 1988-02-26 2001-09-04 Large Scale Biology Corporation Recombinant animal viral nucleic acids
US5260206A (en) * 1988-08-20 1993-11-09 Hoechst Aktiengesellschaft Enzymes for breaking down moenomycins
US5096818A (en) * 1990-06-04 1992-03-17 Autogen Instruments, Inc. Nucleic acid separation method
US5491076A (en) * 1993-11-01 1996-02-13 The Texas A&M University System Expression of foreign genes using a replicating polyprotein producing virus vector
US5939541A (en) * 1997-03-28 1999-08-17 University Of South Carolina Method for enhancing expression of a foreign or endogenous gene product in plants
US6077992A (en) * 1997-10-24 2000-06-20 E. I. Du Pont De Nemours And Company Binary viral expression system in plants
US6632980B1 (en) 1997-10-24 2003-10-14 E. I. Du Pont De Nemours And Company Binary viral expression system in plants
AU2001225441A1 (en) * 2000-01-24 2001-07-31 Agricultural Research Organization The Volcani Center Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
IL151860A0 (en) 2000-03-27 2003-04-10 Technion Res & Dev Foundation Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
WO2002057408A2 (en) * 2001-01-17 2002-07-25 Ramot At Tel Aviv University Ltd. Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
EP1377156A4 (en) * 2001-03-22 2007-08-29 Scentgene Pollination Ltd Method of enhancing entomophilous
US8022190B2 (en) * 2001-06-19 2011-09-20 Technion Research & Development Foundation Ltd. Immuno-molecules containing viral proteins, compositions thereof and methods of using
IL159944A0 (en) * 2001-07-19 2004-06-20 Yissum Res Dev Co Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
US20040121442A1 (en) * 2002-05-05 2004-06-24 Ilan Chet Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
CA2978152C (en) 2003-05-22 2021-01-26 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
AU2005234725B2 (en) 2003-05-22 2012-02-23 Evogene Ltd. Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
EP2343373B1 (en) 2004-06-14 2017-05-10 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
DE602005023332D1 (en) 2004-09-29 2010-10-14 Collplant Ltd COLLAGENPRODUZIERENDE PLANTS AND METHOD FOR THE PRODUCTION AND THEIR USE
EP2484768A3 (en) 2005-07-18 2012-11-21 Protalix Ltd. Mucosal or enteral administration of biologically active macromolecules
MX338183B (en) 2005-10-24 2016-04-06 Evogene Ltd Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same.
KR101442209B1 (en) * 2006-05-19 2014-11-18 테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. Fusion proteins, uses thereof and methods for their production
US8629259B2 (en) 2006-07-20 2014-01-14 Yeda Research And Development Co. Ltd. Photosynthetic organisms and compositions and methods of generating same
BRPI0719602B1 (en) 2006-12-20 2021-05-18 Evogene Ltd nucleic acid construction, and methods for increasing a plant's biomass, for increasing a plant's vigor, for increasing a plant's yield, for increasing a plant's tolerance to abiotic stress, for improving fiber quality and / or yield of a fiber producing plant and to produce cotton fibers
EP2154946B1 (en) 2007-04-09 2013-06-05 Evogene Ltd. Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
US8686227B2 (en) 2007-07-24 2014-04-01 Evogene Ltd. Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
JP2011504374A (en) 2007-11-26 2011-02-10 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド Composition comprising fibrous polypeptide and polysaccharide
AU2008344935C1 (en) 2007-12-27 2016-07-14 Evogene Ltd. Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
US9095569B2 (en) 2008-04-18 2015-08-04 Collplant Ltd. Methods of generating and using procollagen
AU2009239333A1 (en) 2008-04-21 2009-10-29 Danziger Innovations Ltd. Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
US9018445B2 (en) 2008-08-18 2015-04-28 Evogene Ltd. Use of CAD genes to increase nitrogen use efficiency and low nitrogen tolerance to a plant
EP2347014B1 (en) 2008-10-30 2016-09-21 Evogene Ltd. Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
MX350550B (en) 2008-12-29 2017-09-08 Evogene Ltd Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same.
EP3862433A3 (en) 2009-03-02 2021-11-17 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
BRPI1009032B1 (en) 2009-06-10 2019-05-28 Evogene Ltd. METHOD OF INCREASED EFFICIENCY IN THE USE OF NITROGEN, BIOMASS, GROWTH RATE, AND / OR TOLERANCE THE DEFICIENCY OF NITROGEN OF A PLANT
MX2012000271A (en) 2009-06-30 2012-09-07 Yissum Res Dev Co Introducing dna into plant cells.
WO2011048600A1 (en) 2009-10-21 2011-04-28 Danziger Innovations Ltd. Generating genotypic variations in plant genomes by gamete infection
WO2011067745A2 (en) 2009-12-06 2011-06-09 Rosetta Green Ltd. Compositions and methods for enhancing plants resistance to abiotic stress
AU2010337936B2 (en) 2009-12-28 2016-06-23 Evogene Ltd. Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
WO2011099006A2 (en) 2010-02-11 2011-08-18 Yeda Research And Development Co. Ltd. Enzymatic systems for carbon fixation and methods of generating same
EP2563112A4 (en) 2010-04-28 2014-03-05 Evogene Ltd Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
BR112012032126A2 (en) 2010-06-16 2017-10-17 Futuragene Israel Ltd Empresa Isralense isolated polynucleotide, nucleic acid structure, nucleic acid structure system, isolated polypeptide, plant, insecticidal composition, and method for controlling or exterminating an insect
EP2593468B1 (en) 2010-07-12 2020-06-10 The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center Isolated polynucleotides and methods and plants using same for regulating plant acidity
BR112013000984A2 (en) 2010-07-15 2017-10-03 Technion Res & Dev Foundation NUCLEIC ACID STRUCTURE TO INCREASE ABIOTICAL STRESS TOLERANCE IN PLANTS
WO2012032520A1 (en) 2010-09-07 2012-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
CN103237895A (en) 2010-11-03 2013-08-07 耶路撒冷希伯来大学伊森姆研究发展有限公司 Transgenic plants with improved saccharification yields and methods of generating same
KR101883803B1 (en) 2011-01-20 2018-07-31 프로탈릭스 리미티드 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
UA113843C2 (en) 2011-03-02 2017-03-27 BACTERIA TRANSGENIC PLANT CONTAINING T3SS DIFFUNCTIONAL PROTEINS
WO2012156976A1 (en) 2011-05-16 2012-11-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of producing artemisinin in non-host plants and vectors for use in same
UA116097C2 (en) 2011-12-11 2018-02-12 Зе Стейт Оф Ізраел, Міністрі Оф Агрікалче Енд Руерал Девелопмент, Агрікалчерал Рісьоч Організейшн, (А.Р.О.), Волкані Сентре Methods of modulating stomata conductance and plant expression constructs for executing same
US9603907B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Dry powder formulations of dNase I
WO2013118120A2 (en) 2012-02-06 2013-08-15 Rosetta Green Ltd. Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
EP2814838A1 (en) 2012-02-19 2014-12-24 Protalix Ltd. Oral unit dosage forms and uses of same for the treatment of gaucher disease
WO2014033723A1 (en) 2012-09-03 2014-03-06 A.B. Seeds Ltd. Method of improving abiotic stress tolerance of plants and plants generated thereby
US20160017021A1 (en) 2013-03-06 2016-01-21 Protalix Ltd. TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
AU2014224174B2 (en) 2013-03-06 2018-08-30 Hadasit Medical Research Services And Development Ltd. Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
US20170101633A1 (en) 2014-02-10 2017-04-13 Protalix Ltd. Method of maintaining disease stability in a subject having gaucher's disease
US20170283844A1 (en) 2014-09-11 2017-10-05 The State of Israel, Ministry of Agriculture & Rural Development, Argricultural Research Organiza Methods of producing mogrosides and compositions comprising same and uses thereof
WO2016079739A2 (en) 2014-11-20 2016-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
KR20170081268A (en) 2014-11-27 2017-07-11 단지거 이노베이션즈 엘티디. Nucleic acid constructs for genome editing
JP7019580B2 (en) 2016-01-21 2022-02-15 ザ ステイト オブ イスラエル ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント アグリカルチュラル リサーチ オーガニゼイション (エー.アール.オー.) (ボルカニ センター) Parthenogenetic plants and their manufacturing methods
GB201708662D0 (en) 2017-05-31 2017-07-12 Tropic Biosciences Uk Ltd Compositions and methods for increasing shelf-life of banana
GB201708665D0 (en) 2017-05-31 2017-07-12 Tropic Biosciences Uk Ltd Compositions and methods for increasing extractability of solids from coffee beans
WO2018220582A1 (en) 2017-05-31 2018-12-06 Tropic Biosciences UK Limited Methods of selecting cells comprising genome editing events
WO2018224861A1 (en) 2017-06-07 2018-12-13 International Rice Research Institute Increasing hybrid seed production through higher outcrossing rate in cytoplasmic male sterile gramineae plants and related materials and methods
SG11202002481RA (en) 2017-09-19 2020-04-29 Tropic Biosciences Uk Ltd Modifying the specificity of non-coding rna molecules for silencing gene expression in eukaryotic cells
US11541428B2 (en) 2017-12-03 2023-01-03 Seedx Technologies Inc. Systems and methods for sorting of seeds
WO2019106639A1 (en) 2017-12-03 2019-06-06 Seedx Technologies Inc. Systems and methods for sorting of seeds
WO2019106641A2 (en) 2017-12-03 2019-06-06 Seedx Technologies Inc. Systems and methods for sorting of seeds
GB201807192D0 (en) 2018-05-01 2018-06-13 Tropic Biosciences Uk Ltd Compositions and methods for reducing caffeine content in coffee beans
EP3787702B1 (en) 2018-05-03 2024-08-07 CollPlant Ltd. Dermal fillers and applications thereof
EP3802839A1 (en) 2018-06-07 2021-04-14 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Nucleic acid constructs and methods of using same
EP3800998A1 (en) 2018-06-07 2021-04-14 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Methods of regenerating and transforming cannabis
WO2020008412A1 (en) 2018-07-04 2020-01-09 Ukko Inc. Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
GB201903521D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd No title
GB201903519D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
GB201903520D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
WO2021001784A1 (en) 2019-07-04 2021-01-07 Ukko Inc. De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
CA3148950A1 (en) 2019-07-30 2021-02-04 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
WO2021100034A1 (en) 2019-11-19 2021-05-27 Protalix Ltd. Removal of constructs from transformed cells
US20230263121A1 (en) 2020-03-31 2023-08-24 Elo Life Systems Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits
WO2022038536A1 (en) 2020-08-18 2022-02-24 International Rice Research Institute Methods of increasing outcrossing rates in gramineae
WO2022074646A1 (en) 2020-10-05 2022-04-14 Protalix Ltd. Dicer-like knock-out plant cells
US20240060079A1 (en) 2020-10-23 2024-02-22 Elo Life Systems Methods for producing vanilla plants with improved flavor and agronomic production
IL302707A (en) 2020-11-26 2023-07-01 Ukko Inc A subunit of glutenin that has been modified and has a high molecular weight and its uses
US20240141311A1 (en) 2021-04-22 2024-05-02 North Carolina State University Compositions and methods for generating male sterile plants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1192510A (en) * 1981-05-27 1985-08-27 Lawrence E. Pelcher Rna plant virus vector or portion thereof, a method of construction thereof, and a method of producing a gene derived product therefrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VIROLOGY *

Also Published As

Publication number Publication date
EP0136521B1 (en) 1991-01-30
EP0136521A2 (en) 1985-04-10
DE3484039D1 (en) 1991-03-07
US4855237A (en) 1989-08-08
JPS6054684A (en) 1985-03-29
EP0136521A3 (en) 1987-05-20

Similar Documents

Publication Publication Date Title
JPH0258916B2 (en)
Lebeurier et al. In vivo recombination of cauliflower mosaic virus DNA
Heyraud et al. Identification of the initiation sequence for viral‐strand DNA synthesis of wheat dwarf virus.
Woolston et al. Agroinfection and nucleotide sequence of cloned wheat dwarf virus DNA
WO1990002189A1 (en) Expression cassette for plants
Christie et al. Bacteriophage P2 late promoters: II. Comparison of the four late promoter sequences
Bancroft et al. Characterization of an insertion sequence (IS891) of novel structure from the cyanobacterium Anabaena sp. strain M-131
EP0179861A1 (en) Methods and vectors for transformation of plant cells
CN87100463A (en) Plant viruses or alteration of their action
CN113403335A (en) Mulberry leaf type dwarf associated virus MMDaV infectious clone vector and construction method and application thereof
US5914395A (en) Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells
CN105602972B (en) Method based on CRISPR-Cas9 engineered ex vivo adenovirus vector
WO1985004898A1 (en) An improved method of cloning double-stranded rna, and its use in the production of viral gene clones
Sam et al. DESIGN AND TRANSFER OF OsSWEET14-EDITING T-DNA CONSTRUCT TO BAC THOM 7 RICE CULTIVAR.
JPH0258915B2 (en)
JPH0549271B2 (en)
CN109797162A (en) Corium solani infectious clone and its construction method
JPH0549272B2 (en)
JPS61257186A (en) Novel dna and hybrid dna
KR100609565B1 (en) Plant expression vector containing the whole genome mosaic virus
JP2514297B2 (en) BGMV DNA mixture
CN112359092A (en) Construction method of genome short fragment library
Mani et al. Agrobacterium-mediated transformation and gus gene expression in Amaranthuscaudatus
JPH0757193B2 (en) Improved promoter, vector having this vector, plasmid having this vector, and host bacterium having this plasmid
JPH0767647A (en) MYMV-based DNA mixture